September edition - American Academy of Neurology
Transcription
September edition - American Academy of Neurology
YOUR MONTHLY AAN MEMBERSHIP MAGAZINE VOLUME 24 PRESIDENT’S COLUMN AAN Advocacy Focuses on Patients and the Profession, Not Ideologies Advocacy is often the first topic of conversation I have with almost every neurologist I meet, whether it be at a committee meeting, as a visiting professor, or just in my personal interactions with AAN members. This focus on advocacy arises from concerns about the potential and real changes to the health care delivery system being discussed in Washington. Reimbursement for services has a Bruce Sigsbee, MD, FAAN substantial impact on both private and academic practice as it becomes difficult to make ends meet, especially for those who focus on and direct patient evaluation and management, as opposed to procedures. Today, the Academy is in a great position to advocate not only for the profession of neurology but also for our patients. But it took a while to get there. ISSUE 9 SEPTEMBER 2011 Discover Your True Potential Through the 2012 Palatucci Advocacy Leadership Forum AAN members have until September 18 to complete their applications to attend the 10th Annual Donald M. Palatucci Advocacy Leadership Forum. The event will be held in Austin, TX, January 12 to 15, 2012. This award-winning training program is open to international members as well as those in the United States. Participating in the Palatucci Elaine C. Jones, MD, FAAN Forum can be a life-changing experience. Elaine C. Jones, MD, FAAN, attended the first event in January 2003. She recently discussed her reasons for applying and recalled overcoming her initial trepidation as she embarked on a fulfilling journey that helped her rise to the position of the chair of the AAN’s Government Relations Committee: Initially, there was concern that we would lose something as a specialty if we became engaged in advocacy. But eventually, I think we recognized that without a persistent and articulate voice, the value of neurology would not be considered in the competing demands for federal and state resources. To protect our specialty and the access of patients to the expertise of neurologists, we had to become effective advocates for what we do. The Academy began a dramatic increase in the AAN’s advocacy efforts in the early 2000s. For the first time, advocacy staff was hired solely to represent the AAN and a concerted effort was made to develop relationships with patient groups. A Washington, DC, office opened in 2005 and a political action committee, BrainPAC, was created in 2007. At the same time, the AAN participation in committees dealing with coding and reimbursement and quality measures was bolstered. It is my own view that former US House Speaker Tip O’Neill’s quote that “all politics are local” is not quite correct. I think that all politics are personal. In the politics of neurology and health care it is critical that we cultivate personal relationships with key figures Teshamae Monteith, MD, (left) accepted the 2009 Palatucci Advocate of the Year Award from Elaine C. Jones, MD, FAAN. “The Forum has given me the training, skills and confidence to make the plight of headache sufferers known, as well as the need for improved quality of care for headache sufferers, especially veterans and active duty soldiers,” said Monteith. Continued on page 3 p 15 Now Accepting Applications for 2012 Scientific and Non-scientific Awards p 28 New ICD-9 Codes Affect Neurologists Beginning October 1 Continued on page 7 p 31 Neurology Career Week Brings Job Opportunities, Resources to Members TABLE OF CONTENTS PRESIDENT’S COLUMN OFFICIAL PUBLICATION OF THE AMERICAN ACADEMY OF NEUROLOGY COVER AAN Advocacy Focuses on Patients and the Profession, Not Ideologies Discover Your True Potential Through the 2012 Palatucci Advocacy Leadership Forum PRESIDENT’S COLUMN 3 AAN Advocacy Focuses on Patients and the Profession, Not Ideologies ADVOCACY IN ACTION 4 Member Shares, Gains Insights as Neurology Fellow on Congressional Staff 5 Apply for the Viste Patient Advocacy Award by November 30 6 Independent Payment Advisory Board Has Implications for AAN Members 7 Free Webinar to Discuss Viste Neurology Public Policy Fellowship 13 Sports Concussion, Tort Reform Make Headway in State Legislatures ANNUAL MEETING 14 2012 Annual Meeting Set for Historic, Vibrant New Orleans 15 Now Accepting Applications for 2012 Scientific and Non-scientific Awards 16 Abstracts Sought for Integrated Neuroscience, Subspecialty in Focus Programs 21 2012 Preliminary Education Program Available EDUCATION 24 Introducing Mobile Neurology CME 25 Fall Conference Programs Focus on Improving Your Practice’s Bottom Line 26 The AAN Store Comes to Fall Conference 26 Two-day Evidence-based Medicine Training Program Now Provides CME 27Continuum Call for Nominations: Editor-in-Chief OTHER 27 UCNS Practice Tracks in Headache Medicine and Behavioral Neurology & Neuropsychiatry Set to Expire in 2012 FOCUS ON PRACTICE The Vision of the AAN is to be indispensable to our members. The Mission of the AAN is to promote the highest quality patient-centered neurologic care and enhance member career satisfaction. Contact Information American Academy of Neurology 1080 Montreal Avenue St. Paul, MN 55116 USA Phone: (800)879-1960 or (651) 695-2717 (International) Fax: (651)361-4800 Email: [email protected] Website: www.aan.com 28 New ICD-9 Codes Affect Neurologists Beginning October 1 29 Proposal 2012 Medicare Physician Fee Schedule Includes AAN Quality Measures 29 Key Deadline Nears for EHR Incentive Program 30 Registration Ends September 16 for New Webinar on Negotiating with Hospitals and Insurers AAN Executive Director Catherine M. Rydell, CAE MEMBERSHIP Managing Editor: Jason Kopinski 30 Olson to Be Honored by AMA 31 Neurology Career Week Brings Job Opportunities, Resources to Members 31 Call for Volunteers for Neurology’s Abstract Translation Project 32 New Recruitment Concierge Service Assists in Finding Job Candidates 32 New AAN Headquarters Site Gets Visit from Obama Administrator Editor-in-Chief: John D. Hixson, MD Editor: Tim Streeter Writers: Ryan Knoke, Jay Mac Bride, Sarah Parsons, and Lynn Ellen Smith Designers: Siu Lee and Jim Hopwood Email: [email protected] AANnews is published monthly by the American Academy of Neurology. Follow us and be a fan of the Academy: FOUNDATION 33 Foundation Friends 34 | NEUROLOGY CAREER CENTER 37 | DATES AND DEADLINES NEWS BRIEFS • The AAN worked with four other specialties to submit proposed Current Procedural Terminology ® (CPT) coding revisions to the EMG and nerve conduction codes following a mandate to do so by CMS. • In coordination with the American College of Sports Medicine, the AAN represented the National Youth Sports Concussion Coalition at the National Conference of State Legislatures Summit (NCSL) in San Antonio in August to promote the adoption of state legislation to reduce youth sports concussion. State legislators from across the country attended the NCSL Summit. • WriteClick, the rapid online correspondence section in Neurology ®, launched in August. WriteClick, which will replace Neurology’s current correspondence section and will be edited by Past President Robert C. Griggs, MD, FAAN, will appear on the home page of Neurology. All members are invited to add to the online discussions regarding Neurology articles. Learn from colleagues. Share your insights. Join AAN Communities today! www.aan.com/communities AAN Advocacy Focuses on Patients and the Profession, Not Ideologies Continued from cover in Washington and make our case personal. Our daily presence in Washington and BrainPAC accomplish that for us. Our successes since opening the DC office are measurable. We have had legislation introduced and passed that specifically benefits neurology and patients. Members of Congress routinely contact our staff for help with crafting legislation and asking for our support. Our views are considered like never before. In my opinion, it is important that our advocacy efforts primarily focus on issues that directly impact neurology. Our membership has wide-ranging political views from ultraconservative to ultraliberal and everything in between. Our Government Relations Committee mirrors these widespread political views. This can be a perilous situation when faced with issues that go far beyond affecting just neurology. A perfect example is the continuing consideration of the Affordable Care Act (ACA) which began in 2009. The AAN has members disappointed, if not angered, by our refusal to take a position on significant issues such as the adoption of a single-payer system, at the same time others demand support for a complete repeal of the ACA. These issues transcend specialty care and neurology. There are major systematic problems with our current health care delivery system including lack of access for many and unsustainable escalating cost. But as a relatively small organization with limited resources, the AAN’s position on a bill like the ACA is unlikely to change the final outcome. On the other hand, there are components of bills like the ACA where we can have a very real impact. That is where we target our advocacy. Regardless of our political views and passions, as neurologists it is important that we all participate in the political process on behalf of our profession and patients. Increasingly, decisions in Washington and at all levels of government directly impact day-to-day patient care. Our patients depend on us to effectively advocate for their treatments. I encourage you to get to know your elected officials and interact with them or their staff about issues that are important to you on a regular basis. Work for and contribute to candidates you believe in and cultivate long-term relationships with policy makers. Consider running for office yourself. The Academy can help in a number of ways including Neurology on the Hill and the Palatucci Advocacy Leadership Forum (see cover article). Both are extremely valuable experiences. I hope you will join us in the political arena on behalf of yourself, your profession, and your patients. Bruce Sigsbee, MD, FAAN President, AAN ADVOCACY IN ACTION ADVOCACY IN ACTION Member Shares, Gains Insights as Neurology Fellow on Congressional Staff As Larry Charleston, IV, MD, looked back on his experience as the 2010-2011 Kenneth M. Viste, Jr., MD, Neurology Public Policy Fellow (NPPF), one thing was abundantly clear to him: “Politics play a major role in the administration and regulation of health care services and delivery.” Charleston worked for House Ways & Means Health Subcommittee Chair Wally Herger (R-CA) during much of 2011. This was a particularly revealing assignment as the House Ways & Means Committee has dealt with taxes during the current tight fiscal climate, and the Health Subcommittee was grappling with numerous issues affecting health budgets. Charleston said a key factor in his experience as a legislative fellow was finding the “best fit” for his medical background and personal philosophy. “My background and philosophy were graciously and respectfully welcomed in Congressman Herger’s office and I became a member of ‘Team Herger.’ The office found it advantageous to utilize my hands-on medical expertise including patient care, graduate medical education, and training experiences and incorporate my experience in decisions for ‘real world’ applications of health care policy and legislation. My portfolio included working on Medicare reform, physician payment reform, helping to ensure appropriate congressional awareness for the comprehensive diagnosis and treatment for traumatic brainKit injury, AEI: 11 veterans AANStorewith Residents Survival Ad and assisting Congressman Usage: Herger To be output at High Resolution to be placed in AANnews on other health policyPDF initiatives within his office and Specs 8.125"x4.4375": Full bleed +0.125": 4C the House Ways and Means Subcommittee on Health.” Residents and Fellows Kit includes: • QueenSquareHammer,Lanskaedition • 2011 AAN Pocket Guidelines • Ultimate Review for the Neurology Boardsbook Perfectforyourselforasagift A particular anxiety of Herger’s is that the scope of traumatic brain injury, the signature wound of the Iraq and Afghanistan wars, could overwhelm the VA system. “He shared this concern with me,” Charleston said, “and said that we have to get ahead of the problem to ensure that it is handled appropriately. I worked hard to seize this opportunity and to be very instrumental in assisting him in addressing the problem. As a result of Team Herger’s efforts, a Post Larry Charleston, IV, MD Traumatic Headache Consensus was held in Washington, DC, led and attended by members of the American Headache Society.” Charleston’s activities also included speech writing, updating Herger on current key health care policy issues, attending several national health care policy forums and Alliance for Health Care Reform discussions, and providing medical and training insight to many health care issues brought by constituents and organizations. He discussed issues with the Medicare Payment Advisory Committee, helped to formulate questions for the Ways & Means Health Subcommittee hearings, and assisted in the drafts of legislation. “During my tenure as a legislative fellow, I was able to understand grassroots advocacy groups from a congressional staff position. I staffed multiple meetings with constituents, grassroots advocacy groups, organizations, and lobbyists. “Overall, I learned a lot and gained some legislative insight in a short time. Team Herger was awesome! They really helped shape my experience and made a point to include me in important health policy issues. Political decisions have a growing impact on the practice and payment of medicine. I strongly encourage physicians to find ways to actively participate in the legislative process in addition to voting. Also, I encourage us all to get more informed and examine health care policy related legislation (actual and proposed) as well as proposed rules through direct, unfiltered sources.” Charleston’s months in Washington strengthened his belief in the necessity of physician activism. “As neurologists, we can bring the voice of our patients to the legislators revamping our nation’s health care system and foster remarkable changes. Patients Academy Seeks Applicants for Unique Washington, DC, Fellowship Academy members in the US are urged to apply for the 2012–2013 Kenneth M. Viste, Jr., MD, Neurology Public Policy Fellowship by October 15. The fellowship enables AAN members to get firsthand experience in the halls of Congress, including: •Helping draft legislation and taking active part in the policy process •Working with constituents, lobbyists, and congressional committee and office staff •Participating in hearings and special sessions related to policy The fellowship carries an annual stipend of $90,000, which may be supplemented by the fellow’s sponsoring institution or other extramural support. Up to $6,000 is available for relocation. Continued on page 5 Career Kit need competent neurologists who, in addition to providing high-quality neurological care, will advocate for change when they see injustice in clinical practice. The AAN provides multiple advocacy resources and activities where neurologists can make significant differences within the practice of neurology. As the sixth president of the United States, John Quincy Adams, once said, ‘Duty is ours, results are God’s.’ I believe it is our responsibility to exercise our freedom to be a conduit for the voice of our patients, profession, and medical colleagues. This great voice should help mold the reshaping of our health care system.” Larry Charleston, IV, MD, worked on neurology and medical issues with Congressman Wally Herger during his Viste Neurology Public Policy Fellowship. More details on the award, which is sponsored by the AAN, the American Neurological Association, and the Child Neurology Society, can be found at www.aan.com/viste, or by contacting Mike Amery at [email protected]. Register for a free informational webinar held on September 19 at 12:00 p.m. ET at readytalk.com/r/tlh6cojxrc43. Apply for the Viste Patient Advocacy Award by November 30 Each year, the AAN presents the Kenneth M. Viste, Jr., MD, Patient Advocacy Award to a neurologist who exemplifies the kind of leadership and commitment to advocating for the patient community as shown by the award’s namesake. The recipient of this award will have demonstrated a sincere interest and investment in working on behalf of patients with neurologic conditions. In addition to being a former president of the AAN and chair of the AAN Foundation at the time of his death in 2004, Kenneth M. Viste, Jr., MD, was a distinguished neurologist and tireless advocate for his patients. His dedication to improving the lives of others was lauded by his peers and inspired his community. To nominate a colleague or to apply, submit the following: Great value: $89.00 Morethan20%savingsthanif purchasedseparately •A written description of the candidate’s success relating to patient advocacy • If applying, a letter of endorsement from a current AAN member •A list of additional supporters (if any) •A current copy of the candidate’s curriculum vitae www.aan.com/store Applications must be received by November 30, 2011. The recipient will receive a $1,000 honoraria and recognition during the 2012 AAN Annual Meeting in New Orleans. The award is sponsored by the AAN and its Foundation and endowed by gifts from Viste’s friends and colleagues to the Kenneth M. Viste, Jr., MD, Leadership Fund. Kenneth M. Viste, Jr., MD, FAAN For more information, visit www.aan.com/visteaward or contact Julie Grengs at [email protected] or (651) 695-2755. Save Time · Save Money · Shop The AAN Store AANnews • September 2011 5 ADVOCACY IN ACTION ADVOCACY IN ACTION Independent Payment Advisory Board Has Implications for AAN Members In an effort to reduce the growth of Medicare spending, the Patient Protection and Affordable Care Act mandated creating the Independent Payment Advisory Board (IPAB), an outside entity charged with developing cost-saving proposals that would also preserve the quality and access to care for Medicare beneficiaries. Starting in 2013, the Centers for Medicare & Medicaid Services (CMS) will project whether or not Medicare’s per-capita spending growth rate in the following two years will exceed a targeted rate. If projected Medicare spending exceeds the targets, IPAB will propose recommendations to Congress and the president by January 15 the following year on how to reduce the rate. Should Congress take no action by August 15 of that year, IPAB’s proposals will become law and will be automatically implemented by the Department of Health and Human Services (HSS). IPAB’s first proposal with the board’s recommendations would be submitted on January 15, 2014. Here is a brief summary of what neurologists need to know about IPAB and its charter. Discover Your True Potential Through the 2012 Palatucci Advocacy Leadership Forum Continued from cover Implications for Neurology While the goal of the IPAB is to reduce Medicare spending and maintain quality of care and access for Medicare beneficiaries, its cost-saving recommendations are limited. Essentially, the Board is prohibited from raising beneficiary premiums or restricting benefits. It is not prohibited, however, from cutting payments to health care providers and suppliers, which will most likely translate into reducing payments to physicians. Hospitals and hospice are exempted from IPAB’s recommendations for the first four years and clinical labs are exempt for one year. In this respect, neurologists and other physicians providing services to Medicare patients might be subject to the first payment cuts. Currently, physicians would already face payment cuts if the Sustainable Growth Rate formula (SGR), otherwise known as the Medicare reimbursement rate, were to be implemented. The nearly 30-percent SGR cut has been delayed until January 1, 2012, to a large extent, thanks to advocating efforts of the physician and patients’ community. Under IPAB such efforts will be limited. “I wasn’t really sure exactly what it was but I was intrigued by the word ‘advocate’ and wanted to take a larger role in my profession. There are tons of reasons to get involved in the PALF program and for me it was about professional development. I truly had no idea what I was getting into or where it would lead. Prior to this program I hadn’t been involved in the Academy other than attending some Annual Meetings. When I was accepted I was excited but a bit nervous because I didn’t know what would be expected of me. When I went to the first reception it was a little scary because I didn’t know anyone! It took about five minutes for the butterflies to go away. Few people knew each other. Everyone was excited and interested in learning about each other. The AAN staff leading the program was friendly, excited, and reassuring. They made a point to engage people, explain what was expected of us, and emphasize that this was going to be a FUN weekend. “It was one of the most rewarding and exciting experiences of my professional life. I came away energized and with a whole new set of skills. I had also made some friends who, to this day remain close, both personally and professionally. IPAB’s Board Members The board will be comprised of 15 experts, each nominated for six-year terms by the president and confirmed by the Senate; and three nonvoting members: the secretary of HHS, the administrator of the Center for Medicare & Medicaid Services, and the administrator of the Health Resources and Services Administration. Board members should be nationally recognized for their expertise in actuarial science, health finance, health facility management, health plans and delivery systems, and provide broad geographic representation. Inevitably, Medicare patients’ quality of service and access to care will suffer if a large number of neurologists leave the Medicare program due to difficulties remaining profitable. Neurology already is facing difficulties as a cognitive specialty left out of the ‘evaluation and management’ incentive offered to primary care providers. Lower reimbursement rates under this plan most likely would exacerbate these problems. IPAB’s Proposals The IPAB’s proposals cannot recommend rationing health care, raising cost-sharing (including Part A and B premiums) or restricting benefits or eligibility criteria for program’s beneficiaries in any other way. It should limit Medicare spending by identifying sources of excess cost growth while protecting and improving Medicare beneficiaries’ access to services. Most importantly, as an independent entity, the IPAB was granted the authority to create proposals that become laws without congressional action. The board would be only accountable to the president, who appoints its members, so oversight of its work will be highly limited. “The skills I learned that year and in subsequent years have helped me develop in a professional direction that I never imagined. So many doctors complain about the way our profession is heading. We have less time with patients, less autonomy, less satisfaction, and yes, less income. I am trying to be part of the solution rather than continuing to let others take more control. Whether someone wants to improve access to care for a certain patient group, develop support for patients and families, or change regulations that affect our field and our patients, the training at the Palatucci Forum will give them skills and resources to do this. The AAN leaders and staff, the training at the Palatucci Forum, and the connections/friends made during the weekend will aid any neurologist in pursuing these improvements. Academy Support for Repealing IPAB ”Finally, I like to point out that no one should be afraid of failure. In addition, hospitals and hospice will not be subject to cost reductions proposed by the board from 2015 through 2019. Clinical labs also would be exempt for one year. IPAB’s Advisory Reports Besides submitting cost-saving proposals, IPAB also may develop and submit to Congress advisory reports related to Medicare spending. These reports can be submitted each year, beginning January 15, 2014, but they are not to be automatically implemented. For years prior to 2020, advisory reports may include recommendations on how to change payment systems for providers and suppliers in the private sector who are not subject to the board’s proposals. If the board establishes a successful method to control spending for health care providers and suppliers, the private sector may adopt some of the same methods or pressure physicians to offer them similar conditions. The AAN supports the bipartisan efforts in Congress to eliminate the IPAB and has signed on to a letter with hundreds of other physician organizations asking for its repeal. The IPAB effectively removes Medicare spending decisions from Congress and leaves them up to an unelected, unaccountable board. Decisions made by the board likely will have a negative impact on patient access to care by adding to the number of physicians who have already stopped accepting new Medicare patients. Members are encouraged to contact their elected officials in Washington asking them to support the IPAB’s repeal. To review tables that outline how Medicare projected and targeted growth rates and saving targets are to be determined, visit www.aan.com/view/ipabchart. For more information, contact Mike Amery at [email protected]. AANnews • September 2011 6 I still have not been fully successful in my initial Forum project. My project was to reconcile two neurology professional societies in Rhode Island back into one. I wanted to re-energize and strengthen our professional group by getting rid of a ‘town-gown’ split that had occurred many years ago. While this hasn’t completely happened yet, we collaborate more, meet jointly more, and continue to work towards a single stronger voice for neurology in our state. I have learned that success may come in other forms than you first expected. From starting down this road, many other opportunities and projects have come up in which I have been successful. Thanks to the Palatucci Forum, I realize that trying and failing is better than never trying at all. Who knows where it may lead? I am now the chair of the Government Relations Committee for the AAN. I certainly didn’t foresee that when I showed up at that first evening reception. Sometimes all you have to do is take the first step.” Across the world, 270 AAN-trained advocates have been changing lives and improving their profession in significant and lasting ways. Palatucci Forum graduates have successfully advocated for new stroke care centers and time-saving telemedicine initiatives. They have fought for patients to have access to a wider range of antiepileptic drugs, against scope of practice intrusions, and for medical liability reform. Many of these neurologists had no prior advocacy or leadership experience, but they quickly gained confidence and skills through this comprehensive award-winning program. And many, like Jones, have gone on to be leaders in Academy activities. For more information or to apply before the September 18 deadline, visit www.aan.com/view/2012PALF or contact Melissa Larson at [email protected] or (651) 695-2748. Free Webinar to Discuss Viste Neurology Public Policy Fellowship Monday, September 19, 2011, at 12:00 p.m. ET AAN Legislative Counsel Mike Amery hosts a live webinar from Washington, DC, for Academy members interested in learning more about working on Capitol Hill for up to a year as a Kenneth M. Viste, Jr., MD, Neurology Public Policy Fellow. Find out how you can play a role in representing the interests of neurology during this crucial time for your profession. Register by September 15 at readytalk.com/r/tlh6cojxrc43. moderAte-to-severe primAry restless legs syndrome (rls) INTROducINg A first-in-clAss non-dopAminergic treAtment for moderAte-to-severe primAry restless legs syndrome in Adults INdIcATION HORIZANT (gabapentin enacarbil) is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults. HORIZANT is not recommended for patients who are required to sleep during the daytime and remain awake at night. four essential diagnostic criteria for RLS2: • Urge to move the legs—usually accompanied or caused by uncomfortable and unpleasant leg sensations • Symptoms begin or worsen during periods of rest or inactivity such as lying or sitting • Symptoms are partially or totally relieved by movement (walking or stretching) at least as long as the activity continues • Symptoms are worse in the evening or night than during the day or only occur in the evening or night ImPORTANT SAfeTy INfORmATION • HORIZANT 600 mg once daily is the only approved dose. A daily dose of 1,200 mg provided no additional benefit compared with the 600-mg dose, but caused an increase in adverse reactions Effects on Driving • HORIZANT causes significant driving impairment. Patients on HORIZANT should not drive until they have sufficient experience to know whether their ability to drive is impaired. The patients’ ability to assess their driving competence and their ability to assess the degree of somnolence caused by HORIZANT can be imperfect Somnolence/Sedation and Dizziness • HORIZANT causes somnolence/sedation and dizziness. Patients should not drive or operate other complex machinery until they have sufficient experience on HORIZANT to know whether their ability to perform these tasks is impaired Lack of Interchangeability With Gabapentin • HORIZANT is not interchangeable with other gabapentin products due to differing pharmacokinetic profiles. The same dose of HORIZANT results in different plasma concentrations of gabapentin relative to other gabapentin products. Safety and effectiveness of HORIZANT to treat epilepsy is unknown ImPORTANT SAfeTy INfORmATION (cONTINued) Suicidal Behavior and Ideation • HORIZANT (gabapentin enacarbil) is a prodrug of gabapentin, an antiepileptic drug (AED). AEDs increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. As a prodrug of gabapentin, HORIZANT also increases this risk. Patients treated with any AED for any indication should be monitored for new or worsening depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior. Anyone considering prescribing HORIZANT must balance the risk of suicidal thoughts or behavior with the risk of untreated illness. Patients, caregivers, and families should be informed that HORIZANT increases the risk of suicidal thoughts and behavior and should be advised of the need to be alert for new or worsening signs and symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts of self-harm. Behaviors of concern should be reported immediately to healthcare providers Adverse Reactions • The most common adverse reactions for HORIZANT 600 mg, 1,200 mg, and placebo, respectively, were somnolence/ sedation (20%, 27%, and 6%), dizziness (13%, 22%, and 4%), headache (12%, 15%, and 11%), nausea (6%, 7%, and 5%), and fatigue (6%, 7%, and 4%) Discontinuation of HORIZANT • Patients receiving the recommended 600-mg/day dose can discontinue the drug without tapering. If this dose is exceeded, reduce the dose to 600 mg/day for 1 week prior to discontinuation to minimize potential for withdrawal seizure Tumorigenic Potential • In an oral carcinogenicity study, gabapentin enacarbil increased the incidence of pancreatic acinar cell adenoma and carcinoma in male and female rats. The clinical significance of this finding is unknown Please see brief summary of Prescribing Information for HORIZANT on following pages. Visit gsksource.com for more information about HORIZANT. References: 1. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev. 2006;10:153-167. 2. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101-119. For: Licensed from: ©2011 The GlaxoSmithKline Group of Companies and XenoPort, Inc. All rights reserved. Printed in USA. GEN056R0 September 2011 BRIEF SUMMARY HORIZANT ™ (gabapentin enacarbil) Extended-Release Tablets The following is a brief summary only; see full Prescribing Information for complete product information. INDICATIONS AND USAGE HORIZANT™ (gabapentin enacarbil) Extended-Release Tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults. HORIZANT is not recommended for patients who are required to sleep during the daytime and remain awake at night. CONTRAINDICATIONS None. WARNINGS AND PRECAUTIONS Effects on Driving HORIZANT causes significant driving impairment. Patients being treated with HORIZANT should not drive until they have gained sufficient experience to assess whether HORIZANT impairs their ability to drive. However, prescribers and patients should be aware that patients’ ability to assess their own driving competence, as well as their ability to assess the degree of somnolence caused by HORIZANT, can be imperfect. In a 2-week simulated driving study in patients with RLS, a daily 1,200-mg dose of HORIZANT caused significant impairment within 2 hours and for up to 14 hours after dosing. The impairment was similar to that caused by the active control, a single oral dose of diphenhydramine 50 mg. The effect on driving at times other than 2 weeks is unknown. Whether the impairment is related to somnolence [see Somnolence/Sedation and Dizziness] or other effects of HORIZANT is unknown. The 600-mg dose was not studied. Because a 600-mg/day dose of HORIZANT can cause significant somnolence, similar to that of the 1,200-mg/day dose [see Somnolence/Sedation and Dizziness], the 600- and 1,200-mg/day doses may have similar effects on driving behavior. Somnolence/Sedation and Dizziness HORIZANT causes somnolence/sedation and dizziness (see Table 2). Patients should be advised not to drive a car or operate other complex machinery until they have gained sufficient experience on HORIZANT to assess whether HORIZANT impairs their ability to perform these tasks. During the controlled trials in patients with RLS, somnolence/sedation was reported in 20% of patients treated with 600 mg of HORIZANT per day compared with 6% of patients receiving placebo. In those patients treated with HORIZANT who reported somnolence, the somnolence persisted during treatment in about 30%. In the remaining patients, symptoms resolved within 3 to 4 weeks. Dizziness was reported in 13% of patients receiving 600 mg of HORIZANT per day compared with 4% of patients receiving placebo. In those patients treated with HORIZANT who reported dizziness, symptoms persisted during treatment in about 20%. Somnolence/sedation led to withdrawal in 2% of patients receiving 600 mg of HORIZANT per day. Dizziness led to withdrawal in 1% of patients receiving 600 mg of HORIZANT per day. The incidence of these adverse reactions was greater in the patients receiving 1,200 mg per day. Lack of Interchangeability With Gabapentin HORIZANT is not interchangeable with other gabapentin products because of differing pharmacokinetic profiles. The same dose of HORIZANT results in different plasma concentrations of gabapentin relative to other gabapentin products. [See Clinical Pharmacology (12.3) of full prescribing information.] The safety and effectiveness of HORIZANT in patients with epilepsy have not been studied. Suicidal Behavior and Ideation HORIZANT (gabapentin enacarbil) is a prodrug of gabapentin, an antiepileptic drug (AED). AEDs increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Because HORIZANT is a prodrug of gabapentin, HORIZANT also increases this risk. Patients treated with any AED for any indication should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior. Pooled analyses of 199 placebo-controlled clinical trials (monotherapy and adjunctive therapy) of 11 different AEDs showed that patients randomized to 1 of the AEDs had approximately twice the risk [adjusted relative risk 1.8, 95% confidence interval (CI): 1.2, 2.7] of suicidal thinking or behavior compared with patients randomized to placebo. In these trials, which had a median treatment duration of 12 weeks, the estimated incidence rate of suicidal behavior or ideation among 27,863 AED-treated patients was 0.43%, compared with 0.24% among 16,029 placebo-treated patients, representing an increase of approximately 1 case of suicidal thinking or behavior for every 530 patients treated. There were 4 suicides in drug-treated patients in the trials and none in placebo-treated patients, but the number is too small to allow any conclusion about drug effect on suicide. The increased risk of suicidal thoughts or behavior with AEDs was observed as early as 1 week after starting drug treatment with AEDs and persisted for the duration of treatment assessed. Because most trials included in the analysis did not extend beyond 24 weeks, the risk of suicidal thoughts or behavior beyond 24 weeks could not be assessed. The risk of suicidal thoughts or behavior was generally consistent among drugs in the data analyzed. The finding of increased risk with AEDs of varying mechanisms of action and across a range of indications suggests that the risk applies to all AEDs used for any indication. The risk did not vary substantially by age (5 to 100 years) in the clinical trials analyzed. Table 1 shows absolute and relative risk by indication for all evaluated AEDs. Table 1. Risk by Indication for Antiepileptic Drugs in the Pooled Analysis Relative Risk: Placebo Drug Incidence Risk Difference: Patients Patients of Events in Additional With Events With Events Drug Patients/ Drug Patients Per 1,000 Per 1,000 Incidence in With Events Per Indication Patients Patients Placebo Patients 1,000 Patients Epilepsy 1.0 3.4 3.5 2.4 Psychiatric 5.7 8.5 1.5 2.9 Other 1.0 1.8 1.9 0.9 Total 2.4 4.3 1.8 1.9 The relative risk for suicidal thoughts or behavior was higher in clinical trials for epilepsy than in clinical trials for psychiatric or other conditions, but the absolute risk differences were similar for the epilepsy and psychiatric indications. Anyone considering prescribing HORIZANT must balance the risk of suicidal thoughts or behavior with the risk of untreated illness. Epilepsy and many other illnesses for which AEDs are prescribed are themselves associated with morbidity and mortality and an increased risk of suicidal thoughts and behavior. Should suicidal thoughts and behavior emerge during treatment, the prescriber needs to consider whether the emergence of these symptoms in any given patient may be related to the illness being treated. Patients, their caregivers, and families should be informed that HORIZANT increases the risk of suicidal thoughts and behavior and should be advised of the need to be alert for the emergence or worsening of the signs and symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Behaviors of concern should be reported immediately to healthcare providers. Discontinuation of HORIZANT When discontinuing HORIZANT, patients receiving the recommended dose of 600 mg daily can discontinue the drug without tapering. If the recommended dose is exceeded, the dose should be reduced to 600 mg daily for 1 week prior to discontinuation to minimize the potential of withdrawal seizure. Tumorigenic Potential In an oral carcinogenicity study, gabapentin enacarbil increased the incidence of pancreatic acinar cell adenoma and carcinoma in male and female rats [see Nonclinical Toxicology]. The clinical significance of this finding is unknown. In clinical studies of gabapentin as adjunctive therapy in epilepsy comprising 2,085 patient-years of exposure in patients >12 years of age, new tumors were reported in 10 patients (2 breast, 3 brain, 2 lung, 1 adrenal, 1 non-Hodgkin’s lymphoma, 1 endometrial carcinoma in situ), and preexisting tumors worsened in 11 patients (9 brain, 1 breast, 1 prostate) during or up to 2 years following discontinuation of gabapentin. Without knowledge of the background incidence and recurrence in a similar population not treated with gabapentin, it is impossible to know whether the incidence reported in this cohort is or is not affected by treatment. ADVERSE REACTIONS Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. Clinical Trials Experience In all controlled and uncontrolled trials across various patient populations prior to approval of HORIZANT, more than 2,300 patients have received HORIZANT orally in daily doses ranging from 600 to 3,600 mg. The exposure to HORIZANT in 1,201 patients with RLS included 613 exposed for at least 6 months and 371 exposed for at least 1 year. HORIZANT in the treatment of RLS was studied primarily in placebo-controlled trials (n = 642), and in long-term follow-up studies. The population with RLS ranged from 18 to 82 years of age, with 60% being female and 95% being Caucasian. The safety of HORIZANT in doses ranging from 600 to 2,400 mg has been evaluated in 515 patients with RLS in 3 double-blind, placebo-controlled, 12-week clinical trials. The 600-mg dose was studied in 2 of the 3 studies. Eleven out of 163 (7%) patients treated with 600 mg of HORIZANT discontinued treatment due to adverse reactions compared with 10 of the 245 (4%) patients who received placebo. The most commonly observed adverse reactions (≥5% and at least 2 times the rate of placebo) in these trials for the 600-mg dose of HORIZANT were somnolence/sedation and dizziness (see Table 2). Table 2 lists treatment-emergent adverse reactions that occurred in ≥2% of patients with RLS treated with HORIZANT and numerically greater than placebo. Table 2. Incidence of Adverse Reactions in 12-Week RLS Studies Reported in ≥2% of Patients Treated With 600 or 1,200 mg of HORIZANT and Numerically Greater Than Placebo Body System/ Adverse Reaction Nervous system disorders Somnolence/sedation Dizziness Headache Gastrointestinal disorders Nausea Dry mouth Flatulence Placeboa (N = 245) % HORIZANT 600 mg/dayb (N = 163) % HORIZANT 1,200 mg/dayc (N = 269) % 6 4 11 20 13 12 27 22 15 5 2 <1 6 3 3 7 4 2 Table 2 (continued). Incidence of Adverse Reactions in 12-Week RLS Studies Nursing Mothers It is not known whether gabapentin derived from HORIZANT is secreted in human milk; Reported in ≥2% of Patients Treated With 600 or 1,200 mg of HORIZANT and however, gabapentin is secreted into human milk following oral administration of gabapentin Numerically Greater Than Placebo Placeboa (N = 245) % HORIZANT 600 mg/dayb (N = 163) % HORIZANT 1,200 mg/dayc (N = 269) % Body System/ Adverse Reaction General disorders and administration site conditions Fatigue 4 6 7 Irritability 1 4 4 Feeling drunk 0 1 3 Feeling abnormal <1 <1 3 Peripheral edema 1 <1 3 Metabolism and nutritional disorders Weight increased 2 2 3 Increased appetite <1 2 2 Ear and labyrinth disorders Vertigo 0 1 3 Psychiatric disorders Depression <1 <1 3 Libido decreased <1 <1 2 a Placebo was a treatment arm in each of the 3 double-blind, placebo-controlled, 12-week clinical trials. b The 600-mg dose of HORIZANT was a treatment arm in 2 of the 3 double-blind, placebocontrolled, 12-week clinical trials. c The 1,200-mg dose of HORIZANT was a treatment arm in each of the 3 double-blind, placebo-controlled, 12-week clinical trials. Adverse reactions reported in these three 12-week studies in <2% of patients treated with 600 mg of HORIZANT and numerically greater than placebo were balance disorder, blurred vision, disorientation, feeling drunk, lethargy, and vertigo. The following adverse reactions were dose-related: somnolence/sedation, dizziness, feeling drunk, libido decreased, depression, headache, peripheral edema, and vertigo. DRUG INTERACTIONS Neither gabapentin enacarbil nor gabapentin are substrates, inhibitors, or inducers of the major cytochrome P450 enzymes. Gabapentin enacarbil is neither a substrate nor an inhibitor of P-glycoprotein in vitro. Pharmacokinetic drug-drug interaction studies were conducted to examine the potential for an interaction of gabapentin enacarbil with cimetidine and naproxen. No significant pharmacokinetic interactions were observed. No clinically relevant pharmacokinetic interactions are expected between HORIZANT and other substrates of organic cation transporter type 2 (OCT2) and monocarboxylate transporter type 1 (MCT-1) [see Clinical Pharmacology (12.3) of full prescribing information]. USE IN SPECIFIC POPULATIONS Pregnancy Pregnancy Category C. There are no adequate and well-controlled studies with HORIZANT in pregnant women. In nonclinical studies in rat and rabbits, administration of gabapentin enacarbil was developmentally toxic when administered to pregnant animals at doses and gabapentin exposures greater than those used clinically. HORIZANT should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. When pregnant rats were administered gabapentin enacarbil (oral doses of 200, 1,000, or 5,000 mg/kg/day) throughout the period of organogenesis, embryo-fetal mortality was increased at the 2 highest doses and fetal body weights were decreased at the high dose. The no-effect dose for embryo-fetal developmental toxicity in rats is approximately 3 times the recommended human dose (RHD) of 600 mg/day on a body surface area (mg/m2) basis. When pregnant rabbits were administered gabapentin enacarbil (oral doses of 200, 500, or 2,500 mg/kg/day) throughout the period of organogenesis, embryo-fetal mortality was increased and fetal body weights were decreased at the high dose. The no-effect dose for embryo-fetal developmental toxicity in rabbits (500 mg/kg/day) is approximately 16 times the RHD on a mg/m2 basis. When female rats were administered gabapentin enacarbil (oral doses of 200, 1,000, or 5,000 mg/kg/day throughout the pregnancy and lactation periods, offspring growth and survival were decreased at the two highest doses. The no-effect dose for pre- and post-natal developmental toxicity in rats is approximately 3 times the RHD on a mg/m2 basis. In reproductive and developmental studies of gabapentin, developmental toxicity was observed at all doses tested. Increased incidences of hydroureter and/or hydronephrosis were observed in rat offspring following treatment of pregnant animals in studies of fertility and general reproductive performance, embryo-fetal development, and peri- and post-natal development. Overall, a no-effect dose was not established. In mice, treatment of pregnant animals with gabapentin during the period of organogenesis resulted in delayed fetal skeletal ossification at all but the lowest dose tested. When pregnant rabbits were treated with gabapentin during the period of organogenesis, an increase in embryo-fetal mortality was observed at all doses of gabapentin tested. In a published study, gabapentin (400 mg/kg/day) was administered by intraperitoneal injection to neonatal mice during the first postnatal week, a period of synaptogenesis in rodents (corresponding to the last trimester of pregnancy in humans). Gabapentin caused a marked decrease in neuronal synapse formation in brains of intact mice and abnormal neuronal synapse formation in a mouse model of synaptic repair. Gabapentin has been shown in vitro to interfere with activity of the α2δ subunit of voltage-activated calcium channels, a receptor involved in neuronal synaptogenesis. The clinical significance of these findings is unknown. Labor and Delivery The effect of HORIZANT on labor and delivery is unknown. products. Because of the potential for adverse reactions in nursing infants from HORIZANT, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Pediatric Use Safety and effectiveness of HORIZANT in pediatric patients have not been studied. Geriatric Use Of the 515 patients treated with HORIZANT in the 3 double-blind, placebo-controlled, 12-week clinical trials for RLS, 11% were 65 to 74 years of age and 1% were 75 years of age and older. Clinical trials of HORIZANT did not include a sufficient number of patients 65 years and older to determine whether they respond differently from younger individuals. Gabapentin is known to be almost exclusively excreted by the kidney, and the risk of adverse reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, the frequency of dosing may need to be adjusted based on calculated creatinine clearance in these patients [see Dosage and Administration (2.2) of full prescribing information]. Renal Impairment The dose of HORIZANT should be adjusted in patients with renal impairment [see Dosage and Administration (2.2), Clinical Pharmacology (12.3) of full prescribing information]. OVERDOSAGE Human Overdose Experience There have been no reports describing individuals who have taken an overdose of HORIZANT. The highest single dose of gabapentin enacarbil administered to date is 6,000 mg in healthy subjects. At this supratherapeutic dose there were no serious adverse events. The incidence of central nervous system adverse reactions, particularly dizziness and somnolence/sedation, is increased with doses greater than 600 mg daily. Overdosage Management In the event of an overdose, the patient should be treated supportively with appropriate monitoring as necessary. Gabapentin derived from gabapentin enacarbil can be removed by hemodialysis. Standard hemodialysis procedures result in significant clearance of gabapentin. Further management should be as clinically indicated or as recommended by a poison control center. PATIENT COUNSELING INFORMATION See Medication Guide. Physicians should instruct their patients to read the Medication Guide before starting therapy with HORIZANT and to reread it upon prescription renewal for new information regarding the use of HORIZANT. Effects on Driving Patients should be told that HORIZANT can cause significant driving impairment. Accordingly, they should be advised not to drive a car or until they have gained sufficient experience on HORIZANT to assess whether HORIZANT impairs their ability to drive. Patients should be told that it is not known how long this effect lasts. Somnolence/Sedation and Dizziness Patients should be told that HORIZANT can cause significant somnolence and dizziness. This typically resolves within several weeks of initiating treatment. Accordingly, they should be told not to operate dangerous machinery until they have gained sufficient experience on HORIZANT to assess whether HORIZANT impairs their ability to operate dangerous machinery safely. Suicidal Behavior and Ideation Patients, their caregivers, and families should be counseled that HORIZANT may increase the risk of suicidal thoughts and behavior, and should be advised of the need to be alert for the emergence or worsening of symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Behaviors of concern should be reported immediately to healthcare providers. Lack of Interchangeability With Gabapentin Patients should be advised that doses of HORIZANT and other gabapentin products are not interchangeable. Dosing Instructions • Patients should be instructed to take HORIZANT only as prescribed. • HORIZANT should be taken once daily with food at about 5 PM. • If the dose is not taken at the recommended time, the patient should take the next dose at about 5 PM the following day. • Tablets should be swallowed whole and should not be cut, crushed, or chewed. HORIZANT is a trademark of GlaxoSmithKline. Manufactured by: Patheon Inc. Research Triangle Park, NC 27709 For: Licensed from: GlaxoSmithKline Research Triangle Park, NC 27709 XenoPort, Inc. Santa Clara, CA 95051 ©2011, GlaxoSmithKline. All rights reserved. GEN074R0 April 2011 HZT:1BRS ADVOCACY IN ACTION Sports Concussion, Tort Reform Make Headway in State Legislatures Despite continuing budget troubles which resulted in several special sessions (and one state government shutdown), legislatures and assemblies across the country were able to implement numerous policies supported by the AAN, especially regarding the issue of youth sports concussion. The Academy continues to partner with patient groups, state medical associations, and other physician organizations to educate legislators about the AAN’s positions. Issues tracked by the Academy are determined by the Government Relations Committee, which evaluates state priorities on an annual basis. The following is a summary of state actions through July 2011. Visit www.aan.com/advocacy for a more extensive listing of issues the AAN has been tracking. Sports Concussion Fifteen states (Alaska, Arizona, Colorado, Indiana, Iowa, Kansas, Louisiana, Maryland, Minnesota, Nebraska, North Carolina, North Dakota, South Dakota, Texas, and Utah) have enacted sports concussion laws in 2011 with another four awaiting the signature of the governor as of this writing (Delaware, Illinois, Missouri, and New York). Assuming those bills are signed, this brings the total number of states enacting sports concussion laws to 28. Earlier this year, the AAN joined the National Youth Sports Concussion Coalition, an organization headed by the American College of Sports Medicine. Both organizations represented the coalition at the National Conference of State Legislatures Summit, which took place in San Antonio in August, to promote the need to implement sports concussion regulations to legislators representing states that have yet to act. Tort Reform The results of the 2010 elections on state legislatures may have tipped the scales in favor of medical malpractice reforms. Many bills, including some putting new caps on non-economic damages, finally made their way through the legislative process. Of the 21 bills the Academy was tracking, eight states enacted new reforms (Florida, Oklahoma, Pennsylvania, South Carolina, Texas, Tennessee, Virginia, and Utah). Of note is Texas, which enacted a “Loser Pays” law that says that a plaintiff must pay the winning party’s legal fees if their complaint is judged to be groundless. Signed by Governor Rick Perry in May, the new law should result in fewer frivolous lawsuits and lower litigation costs. And the North Carolina legislature overrode a gubernatorial veto of a tort reform bill that includes provisions that should improve the liability climate in that state. The new law includes language that limits the amount of non-economic damages to $500,000. Stroke Arizona, Nevada, and South Carolina enacted legislation that implements new provisions pertaining to stroke protocols. Of note is what took place in South Carolina, where Governor Nikki Haley originally vetoed legislation enacting the Stroke Prevention Act of 2011. However, the legislature was able to override it, making the bill become law. The Academy has been working with the American Stroke Association to help educate legislators on the issue of stroke, as well as to help appoint stroke experts to task forces and committees when called for. Antiepileptic Drugs (AEDs) The Academy tracked bills in Connecticut, Indiana, Iowa, and New York related to AEDs in 2011. Iowa passed legislation that creates a task force studying the AEDs. Progress has been made in other states, including Indiana, where the state senate passed legislation that would have required a pharmacist to alert the prescribing physician and patient when a switch is made. Unfortunately, the bill did not pass the House before adjournment. And as of this writing, a bill in Connecticut was still alive waiting for a vote on the floor. The Academy will continue its partnership with the Epilepsy Foundation on this issue moving forward. ANNUAL MEETING ANNUAL MEETING 2012 Annual Meeting Set for Historic, Vibrant New Orleans Now Accepting Applications for 2012 Scientific and Non-scientific Awards The 64th AAN Annual Meeting is coming to New Orleans April 21 through 28, 2012. History, architecture, culture, art, music, literature—and, of course, food—abound in New Orleans, one of American’s most unique, authentic, and exciting destinations. Regardless of age, interest, or length of stay, there are countless ways to explore, indulge, and create lasting memories in this often referred to as “most European” of American cities. golfing, fishing, and other outdoor recreational activities among the natural beauty of New Orleans. The AAN is now accepting applications to recognize the next wave of bright minds and their remarkable accomplishments. The 2012 AAN scientific and non-scientific awards will be presented at the 64th AAN Annual Meeting in New Orleans. Learn more at the New Orleans Visitors Guide at www.neworleansinfo.com. Information and application instructions for these prestigious awards are available at www.aan.com/view/2012awards. Visit the World-famous Historic French Quarter Early Online Registration Opening in October! Look to www.aan.com/am beginning in October to take advantage of early registration discounts to the 2012 Annual Meeting. More than 100 square-blocks of art, dining, shopping, entertainment, and architectural treasures abound in the world-famous French Quarter. Climb aboard a mule-drawn carriage for a romantic tour of the cobblestone streets. Take in One—or More—Exciting Walking Tours •History tours •Literary tours •Architectural tours •Ghost tours •Movie tours featuring sites from Interview with the Vampire, The Curious Case of Benjamin Button, Pretty Baby, and The Pelican Brief •More Photographer: Richard Nowitz Experience World-famous Music Scene and New Orleans Jazz & Heritage Festival No city loves music more than New Orleans, and in this city music abounds from the streets, clubs, churches, concert halls, and just about everywhere. Consider extending your stay after the Annual Meeting to take in the famous annual New Orleans Jazz & Heritage Festival, set for April 27 to May 6. Learn more at www.nojazzfest.com. Take a Ride on a Famous Historic Streetcar Choose from one of three operating streetcar lines in New Orleans; climb aboard and slide onto one of the wooden seats, and explore St. Charles Avenue, Riverfront Street, and Canal Street. Go on a Culinary Journey Photographer: Carl Purcell Experience America’s most delicious city and take in all the smells and flavors of classic New Orleans’ cuisine—seafood, Cajun, Creole—that make dining a memorable occasion. Scientific Awards Non-scientific Awards Applications for all scientific awards are due November 1, 2011. Contact Erin Jackson at [email protected] or (651) 695-2704 to learn more. Application deadlines and contact information vary. •AAN Alliance Awards: Founders and S. Weir Mitchell •Dreifuss-Penry Epilepsy Award •John Dystel Prize for Multiple Sclerosis Research •Sheila Essey Award: An Award for ALS Research •Norman Geschwind Prize in Behavioral Neurology •Lawrence C. McHenry Award: An Award for the History of Neurology •Medical Student Essay Awards: -- G. Milton Shy Award in Clinical Neurology -- Saul R. Korey Award in Experimental Neurology -- Roland P. Mackay Award in Historical Aspects -- Extended Neuroscience Award •Movement Disorders Research Award •Neuroscience Research Prize •Neuroendocrine Research Award •Michael S. Pessin Stroke Leadership Prize •Mitchell B. Max Award for Neuropathic Pain •Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Diseases •Research Award in Geriatric Neurology •The Bruce S. Schoenberg International Award in Neuroepidemiology •Sleep Science Award •Jon Stolk Award in Movement Disorders for Young Investigators •Harold Wolff-John Graham Award: An Award for Headache/Facial Pain Research •Wayne A. Hening Sleep Award for Young Investigators Clinical Research Training Fellowship Applications Due October 1 Residents, fellows, and trainees are encouraged to apply for a Clinical Research Training Fellowship from the AAN Foundation. Fellowships provide up to three years of salary and protected time in variety of research areas. Start your application today at www.aan.com/go/foundation/research. Immerse Yourself in Unparalleled Culture and Arts From the Arts District to Magazine Street, New Orleans is filled with vibrant, diverse neighborhoods alive with galleries, shopping, dining, and special events all year around. Explore the Great Outdoors Discover live alligators and swamp irises in bloom on organized swamp tours, experience a jazz or harbor cruise on an authentic paddlewheel boat on the Mighty Mississippi, or simply enjoy •Kenneth M. Viste, Jr., MD, Neurology Public Policy Fellowship October 15, 2011 / Mike Amery, [email protected] or (202) 506-7468 •NEW! Patient Safety Award November 1, 2011 / Amy Wallace, [email protected] or (651) 695-2817 •Resident Scholarship to the Annual Meeting November 1, 2011 / Cheryl Alementi, [email protected] or (651) 695-2737 •Program Directors Recognition Award November 1, 2011 / Lucy Persaud, [email protected] or (651) 695-2741 •International Scholarship Award November 1, 2011 / Franziska Schwarz, [email protected] or (651) 695-2807 •Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award November 30, 2011 / Julie Grengs, [email protected] or (651) 695-2755 •AAN Award for Creative Expression of Human Values in Neurology December 1, 2011 / Karen Kasmirski, [email protected] or (651) 695-2731 •Minority Scholars Program December 1, 2011 / Wendy Vokaty, [email protected] or (651) 695-2714 •H. Richard Tyler Award December 1, 2011 / Susan Corcoran, [email protected] or (651) 695-2758 •2013 A.B. Baker Award for Lifetime Achievement in Neurologic Education January 31, 2012 / Nancy Poechmann, [email protected] or (651) 695-2812 NEW! Education Research Grant Available to Study AAN CME Programs at 2012 Annual Meeting A new education research grant of up to $11,500 is available to Associate or Active members of the AAN to study the effectiveness of neurologic education programs offered by the AAN at the 2012 Annual Meeting in New Orleans. The deadline to apply is October 3, 2011. For more information, eligibility requirements, and an application, visit www.aan.com/go/education/eduresearch. Photographer: Richard Nowitz AANnews • September 2011 14 AANnews • September 2011 15 ANNUAL MEETING Abstracts Sought for Integrated Neuroscience, Subspecialty in Focus Programs The AAN seeks abstracts in key topic areas to round out scientific programming at the 2012 Annual Meeting in New Orleans. Submissions are due October 24, 2011. Integrated Neuroscience Sessions will be offered in the following areas: •RNA Metabolism in Neurodegeneration •Plasticity in Basal Ganglia Therapy •Biomarkers in Neurologic Diagnosis and Therapeutic Monitoring •Stem Cells •Mitochondrial Diseases in Neurology •Non-memory Systems in the Brain •The Essential Role of Neurologists in Treating and Preventing Stroke •Pediatric Movement Disorders •Epilepsy and Channelopathies •Peripheral Nerve Regeneration Many of these sessions will be part of the popular Subspecialty in Focus programs, which will focus on: •Aging •Cerebrovascular Disease •Child Neurology •Epilepsy •Movement Disorders •Peripheral Nerve Disorders The AAN also seeks abstracts for the Future of Neuroscience Conference: Translational Neuroscience, a daylong program featuring platform presentations, poster sessions, and invited speakers. These programs are in addition to the wide variety of neuroscience topics for which abstracts are being sought. AEI: 2011: Career Week Ad USAGE: To be exported as High Res PDF for Neurology Journal SPECS: 8.25"x5.4375": Full bleed +0.125": BW Submitters should complete the online form at www.aan.com/go/science for their work to be considered. Please visit www.aan.com/go/am12 for a pdf of the Call for Abstracts. For more information, contact Erin Jackson at [email protected] or (651) 695-2704. 2012 Call for Abstracts Many patients treated for MS still face disease activity Expect your patients to be 64th AAN Annual Meeting New Orleans Ernest N. Morial Convention Center April 21–28, 2012 Early Registration Deadline March 28, 2012 Abstract Submission Scientific and Non-scientific Awards Preliminary Education Program 1 Your Next Career Move Starts at Neurology Career Week! The only FREE job fair specific to neurology comes to you online, October 10 through 14: • • • • • • • OnlineJobFair:chatonlinewithemployers OnlineJobSearch:hundredsofneurologypostings C.V.Reviews:submityoursforfeedback MockInterviews:practiceyourinterviewskillsviaSkype FREEdailywebinarsonavarietyofimportantcareertopics DailyAANStoreSpecials Prizesandmore! www.aan.com/careers Someactivitieshavedeadlines.Seewebsitefordetails. morE activE than thEir DisEasE. Many patients treated for MS still face disease activity Expect your patients to be morE activE than thEir DisEasE. thErE’s an urgEnt nEED to aDDrEss thE signs of DisEasE activity TODAY’S DECISIONS DETERMINE TOMORROW’S OUTCOMES Disease activity in patients with MS should be a sign that those patients may not be responding to treatment. With recurring relapses comes the risk of irreversible damage.1 And, evidence shows that half of patients may experience rapid physical decline once they reach an EDSS of 4.0. 2 Therefore, it is urgent that immediate action be taken at the first signs that disease activity is not adequately managed. Intervening with the right therapy at the right time can make a significant impact on relapse rates, disability progression, MRI results, and patients’ quality of life. signs that inDicatE a patiEnt may not bE rEsponDing to trEatmEnt can bE mEasurED—anD assEssED In addition to evaluating annual MRIs and relapses, disease activity can be measured in-office using multiple validated assessment tools. The timed 25-foot walk and 9-hole peg tests, as well as the MSIS-29 and the SF-36, provide valuable diagnostic assessments of the physical-, mental-, and quality of life–related effects of disease progression. These tools make it feasible to document ongoing disease activity and respond to changes with immediate action before patients experience further disease progression. for morE information, plEasE visit www.awareofthemsigns.com BECAUSE ThEY ShOULD ExpECT TO BE MORE ACTIvE ThAN ThEIR DISEASE, YOU ShOULD ACCEpT NOThINg LESS. ANNUAL MEETING 2012 Preliminary Education Program Available The preliminary Education Program for the 2012 Annual Meeting in New Orleans is now available. The innovative program will allow attendees to customize their schedules with a selection of more than 160 programs in general neurology, specialty areas, practice management, and more. The program’s broad range of topics combine education and science to appeal to all levels of expertise, and provide a curriculum-based program to specifically meet the needs of neurologists interested in particular topic areas. “This year, the AAN Annual Meeting will have an exciting lineup of educational offerings,” said Education Committee Chair Cynthia L. Comella, MD, FAAN. “The program provides opportunities for attendees to participate in a variety of courses related to diverse topics at differing levels of expertise using varied educational methods. Included in the program will be the popular Morning Reports, clinical skills pavilions, self-assessment courses, NeuroFlashes, and the didactic review and update courses. Additionally, in collaboration with the Science Committee and subspecialty societies, there will be six Subspecialty in Focus programs. These will highlight advanced educational topics combined with a scientific Integrated Neuroscience program in specific subspecialty areas, allowing a concentrated focus on a topic over a continuous one-and-a-half-day period. Furthermore, the AAN will provide attendees with the opportunity to develop an individual curriculum of courses and scientific activities to meet their specific needs. I look forward to seeing you in New Orleans!” For more information about the 2012 Annual Meeting Education Program, contact Amy Nostdahl at [email protected] or (651) 332-8687. 2012 Annual Meeting Education Program Tentative Schedule Saturday, April 21 A.M. Half-Day Courses / 8:00 a.m.–12:00 p.m. 1AC.001 Resident Basic Science I: Neuropathology 1AC.002 Deep Brain Stimulation Management 1AC.003 Diagnostic Dilemmas in Multiple Sclerosis 1AC.004 Neuromuscular Junction Disorders Education Directors Program / 8:00 a.m.–4:00 p.m. 1EP.001 Clerkship and Program Directors Conference Full-Day Course / 8:00 a.m.– 4:00 p.m. 1FC.001 The Practice of Neurology: Issues in Coding and Reimbursement P.M. Half-Day Courses / 2:00 p.m.–6:00 p.m. 1PC.001 Peripheral Neuropathy Therapy– Subspecialty in Focus Program 1PC.002 Resident Basic Science II: Functional Neuroanatomy FOR MORE INFORMATION, PLEASE VISIT www.AwareOfTheMSigns.com References: 1. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology. 2003;61:1528-1532. 2. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000;343:1430-1438. © 2011 01/11 Kick-Off Programs / 4:00 p.m.–6:00 p.m. 1KP.001 The Neurohospitalist Model: Why, How, and Implications Thereof 1KP.002 Top 10 Neuro-ophthalmic Diagnoses You Can't Afford to Miss 1KP.003 Multiple Sclerosis (Quint)Essentials 1KP.004 Recognition and Management of the Many Types of Status Epilepticus 1KP.005 Surviving Stroke Call: A Guide for Nonvascular Neurologists 1KP.006 Diagnostic Testing in Neuromuscular Disease* 1KP.007 Borderlands of Neurology and Internal Medicine 1KP.008 Assessment of Rapidly Progressive Dementias and Related Neurologic Conditions Sunday, April 22 Morning Report / 6:30 a.m.–8:00 a.m. 2MR.001 Morning Report: Memory Disorders Neuro Flashes / 6:30 a.m.–8:00 a.m. 2NF.001 Neuro Flash: Sleep Medicine 2NF.002 Neuro Flash: Acute Stroke Management 2NF.003 Neuro Flash: MRI and Multiple Sclerosis* Seminars / 6:30 a.m.–8:30 a.m. 2SM.001 Introduction to Genetics 2SM.002 Starting Your Career: The Early Years* Extended Seminars / 6:30 a.m.–9:30 a.m. 2ES.001 Clinical E-Pearls 2ES.002 EEG In Children: Developmental Maturation, Variants, Epilepsy Syndromes, and Identification of Surgical Candidates A.M. Half-Day Courses / 9:00 a.m.–1:00 p.m. 2AC.001 Headaches in Adults I 2AC.002 Child Neurology I 2AC.003 Resident Basic Science III: Neuropharmacology 2AC.004 Non-Alzheimer's Dementia 2AC.005 Sports Neurology 2AC.006 Emergency Room Neuro-ophthalmology 2AC.007 What’s in a Stroke Center: Members, Services, Organization and Roles– Subspecialty in Focus Program Seminars / 9:30 a.m.–11:30 a.m. 2SM.003 Practice Survival for Neurologists: Business Strategies for Success* 2SM.004 Clinical Grant Writing Full-Day Courses / 10:00 a.m.–6:00 p.m. 2FC.001 Clinical Epilepsy 2FC.002 Neurologic Intensive Care 2FC.003 Movement Disorders 2FC.004 Therapy in Neurology 2FC.005 Infections of the Nervous System Skills Workshop / 10:00 a.m.–6:00 p.m. 2SW.001 EMG Skills Workshop: Basic P.M. Half-Day Courses / 2:00 p.m.– 6:00 p.m. 2PC.001 Headaches in Adults II 2PC.002 Child Neurology II 2PC.003 Autoimmune Neurology 2PC.004 Spine Neuroimaging: Clinical-Radiologic Correlation 2PC.005 White Matter Disease in Cognitive Aging–Subspecialty in Focus Program 2PC.006 Inherited Neuropathies: From Bench to Bedside–Subspecialty in Focus Program Monday, April 23 Morning Report / 6:30 a.m.– 8:00 a.m. 3MR.001 Morning Report: Multiple Sclerosis Continued on page 22 3-8196-01 AANnews • September 2011 21 ANNUAL MEETING ANNUAL MEETING 2012 Preliminary Education Program Available 2012 Preliminary Education Program Available Continued from page 21 Continued from page 22 Neuro Flashes / 6:30 a.m.–8:00 a.m. 3NF.001 Neuro Flash: Approach to Acute CNS Infections 3NF.002 Neuro Flash: Opioid Therapy for Headache and Neuropathic Pain Syndromes: Consensus and Controversies Seminars / 6:30 a.m.–8:30 a.m. 3SM.001 Mitochondrial Disorders in Neurology 3SM.002 Career Development for Clinician Educators 3SM.003 Global Health Challenges: Neurology in Developing Countries Extended Seminars / 6:30 a.m.–9:30 a.m. 3ES.001 Making Sure Your Electronic Health Record System Is a Success 3ES.002 Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia A.M. Half-Day Courses / 9:00 a.m.–1:00 p.m. 3AC.001 Stroke in Children and Neonates 3AC.002 Clinical Practice Survival Guide 3AC.003 Multiple Sclerosis Overview I: Basic Science 3AC.004 Sleep for the Practicing Neurologist 3AC.005 Neuro-oncology: Primary Brain Tumors 3AC.006 Vascular Contributions to Cognitive Impairment and Dementia–Subspecialty in Focus Program 3AC.007 Emerging Techniques and Directions in Epilepsy–Subspecialty in Focus Program 3AC.008 Impulse Control Disorders and Reward Mechanisms in Movement Disorders– Subspecialty in Focus Program Seminar / 9:30 a.m.–11:30 a.m. 3SM.004 Spine and Spinal Cord Emergencies 3SM.005 Archival Neurologic Films Full-Day Courses / 10:00 a.m.–6:00 p.m. 3FC.001 Genetics in Neurology 3FC.002 Cerebrovascular Disease 3FC.003Neuro-ophthalmology 3FC.004 Peripheral Neuropathy 3FC.005 Neurology Update I Skills Workshop / 10:00 a.m.–6:00 p.m. 3SW.001 Neurophysiologic Intraoperative Monitoring Extended Seminars / 11:00 a.m.–2:00 p.m. 3ES.003 Palliative Care 3ES.004 Improving Accuracy of Dementia Diagnosis: Case Studies with Both Imaging and Neuropathology P.M. Half-Day Courses / 2:00 p.m.–6:00 p.m. 3PC.001 Bedside Evidence-Based Medicine: How to Deconstruct Articles in Order to Take Care of Patients 3PC.002 Multiple Sclerosis Overview II: Clinical Advances 3PC.003 Continuum ® Test Your Knowledge: A Multiple-Choice Question Review 3PC.004 Neurologic Complications of Systemic Cancer 3PC.005Neuropsychiatry–Subspecialty in Focus Program 3PC.006 Evaluation and Management of Autonomic Disorders Tuesday, April 24 Seminars / 6:30 a.m.–8:30 a.m. 4SM.001 Case Studies in Neuro-oncology 4SM.002 E/M: Minimize Mistakes, Maximize Reimbursement 4SM.003 The Dystonias: Diagnosis, Treatment, and Update on Causes 4SM.004 Editor's Seminar: Tips for Writing and Reviewing in Neurology ® 4SM.005 Mild Cognitive Impairment: Implications for Clinicians 4SM.006 Nystagmus: An Organized Approach* Neurology Skills Pavilion / 1:00 p.m.–5:00 p.m. 4NP.001 Neurology Skills Pavilion: Neuromuscular Bedside Rounds P.M. Half-Day Courses / 1:00 p.m.–5:00 p.m. 4PC.001 Pain Management Basics: A Primer for Neurologists 4PC.002 History of Neurology: The Origins of the Neurological Examination 4PC.003 Cumulative Sports Concussion and Risk of Dementia 4PC.004 Practical Legal Issues for Neurologists 4PC.005 Epilepsy, Brain Injury, and Cognitive Costs–Subspecialty in Focus Program 4PC.006Myoclonus–Subspecialty in Focus Program Wednesday, April 25 Seminars / 6:30 a.m.–8:30 a.m. 5SM.001Neurotoxicology 5SM.002 Case Studies: Clinical Ethics, Professionalism, and Evidence-based Care of Patients with Severe Life-limiting Neurologic Disease* 5SM.003 Psychogenic Movement Disorders 5SM.004 Brain Computer Interfaces: Frontiers in Neurology and Neuroscience 5SM.005 The Neurology of Social Behavior 5SM.006 Small Fiber Neuropathies: Somatic, Autonomic, or a Mixture of Both Neurology Skills Pavilion / 2:00 p.m.–6:00 p.m. 5NP.001 Neurology Skills Pavilion: Neuro-ophthalmology and Neurovestibular Exam Lab P.M. Half-Day Courses / 2:00 p.m.–6:00 p.m. 5PC.001Myelopathies 5PC.002 Neurology Telemedicine Systems 5PC.003 Women's Neurologic Issues in Pregnancy 5PC.004 Parkinson's Disease and Movement Disorders Update P.M. Skills Workshop / 2:00 p.m.– 6:00 p.m. 5PW.001 Acute Stroke Alert Skills Workshop Thursday, April 26 Neuro Flashes / 6:30 a.m.–8:00 a.m. 6NF.00 Neuro Flash: Epilepsy 6NF.002 Neuro Flash: Thunderclap Headache: The Big, the Bad and the Ugly Seminars / 6:30 a.m.–8:30 a.m. 6SM.001 Hallucinations in Parkinson’s Disease 6SM.002 What Neurologists Really Need to Know About Normal Pressure Hydrocephalus 6SM.003 Attention Deficit Hyperactivity Disorder Across the Lifespan Skills Workshop / 11:30 a.m.–7:00 p.m. 6SW.001 Advanced Techniques in EMG and Neuromuscular Disease Neurology Skills Pavilion / 1:00 p.m.–5:00 p.m. 6NP.001 Epilepsy Skills Pavilion P.M. Half-Day Courses / 1:00 p.m.–5:00 p.m. 6PC.001 Hot Topics in Headaches and Related Disorders* Continued on page 23 AANnews • September 2011 22 6PC.002 Clinical EMG I 6PC.003 Neurologic Complications of Medical Disease 6PC.004 Update on Endovascular Treatment of Cerebrovascular Diseases 6PC.005Leukodystrophies–Subspecialty in Focus Program 7AC.004 Botulinum Toxins: Practical Issues and Clinical Uses for Neurologists 7AC.005 Clinical Issues in Multiple Sclerosis 7AC.006 Traumatic Brain Injury Case Studies Programs / 6:00 p.m.–9:00 p.m. 6CS.001 Case Studies: Neuroimaging 6CS.002 Case Studies: Multiple Sclerosis 6CS.003 Case Studies: Unusual Movement Disorders 6CS.004 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease 6CS.005 Case Studies in Behavioral Neurology Full-Day Courses / 9:00 a.m.–5:00 p.m. 7FC.001 Update in Neuroimaging: Essentials and Beyond–Part I 7FC.002 Dementia Update 7FC.003 Clinical EEG 7FC.004 Neurology Update II Friday, April 27 Therapy Programs / 12:00 p.m.–2:00 p.m. 7TP.002 Therapy of Multiple Sclerosis 7TP.003 Therapy of Movement Disorders Morning Report / 6:30 a.m.–8:00 a.m. 7MR.001 Morning Report: Challenging Headache Cases Neuro Flashes / 6:30 a.m.–8:00 a.m. 7NF.001 Neuro Flash: Neuro-ophthalmology 7NF.002 Neuro Flash: Child Neurology Seminars / 6:30 a.m.–8:30 a.m. 7SM.001 Balance and Gait Disorders 7SM.002 Therapeutic Hypothermia* 7SM.003 Vaccines and Neurologic Adverse Events 7SM.004 Differential Diagnosis of Dementia: Linking Clinical Syndromes to Biomarkers A.M. Half-Day Courses / 8:00 a.m.–12:00 p.m. 7AC.001 Diagnosis and Management of Leukodystrophies 7AC.002 Clinical EMG II 7AC.003 Sleep Disorders in Clinical Neurology Therapy Program / 9:00 a.m.–11:00 a.m. 7TP.001 Therapy of Stroke Neuroscience Conference / 9:00 a.m.–5:00 p.m. 7SC.001 Future of Neuroscience Conference: Translational Neuroscience P.M. Half-Day Courses / 1:00 p.m.–5:00 p.m. 7PC.001Neuro-otology 7PC.002 Primer of Behavioral Neurology 7PC.003 Special Topics in the Neurology of Sleep 7PC.004 Emergency Neurology 7PC.005 Common Spine Disorders 7PC.006 Neurodevelopmental Disorders– Subspecialty in Focus Program P.M. Skills Workshop / 1:00 p.m.–5:00 p.m. 7PW.001 Clinical Usefulness of Botulinum Toxin and Treatment of Dystonia Therapy Programs / 3:00 p.m.–5:00 p.m. 7TP.004 Therapy of Headache 7TP.005 Therapy of Neuromuscular Disease Are You Getting Your AANe-news? Don’t miss the latest news headlines from your Academy! As an exclusive member benefit, you should be receiving AANe-news™ the second and fourth Wednesday of each month if your email address is on file. If not, be sure to set your email filter to accept [email protected] as a friendly address. Or update your email address at www.aan.com/go/membership. It’s Not Spam… It’s AANe-news! Saturday, April 28 Seminars / 6:30 a.m.–8:30 a.m. 8SM.001 Sleep in CNS Disorders 8SM.002 Vascular Cognitive Impairment and Dementia: Current Status and Future 8SM.003 Pediatric Pseudotumor Cerebri: From Diagnosis to Treatment 8SM.004 Update on Ataxias 8SM.005 You Make the Call–An Interactive, Multimedia, Case-Based Approach to Learning EMG Waveform Analysis Extended Seminars / 6:30 a.m.–9:30 a.m. 8ES.001 Criteria for Stopping and Starting Multiple Sclerosis Therapy 8ES.002 Acute Encephalopathy A.M. Half-Day Courses / 9:00 a.m.–1:00 p.m. 8AC.001 Update in Neuroimaging: Essentials and Beyond–Part II 8AC.002 Neuromyelitis Optica: Scientific and Clinical Update 8AC.003 Consultations in the Medical Surgical ICU 8AC.004 How to Analyze Spells by Video-EEG 8AC.005 Clinical Approach to Muscle Disease 8AC.006 Psychiatry for the Neurologist Seminars / 9:30 a.m.–11:30 a.m. 8SM.006 Learning Movement Disorders in Hindsight: Lessons from My Patients 8SM.007 Common and Important Ophthalmoscopic Findings* * Indicates the program has been selected for rotation Program subject to change. Current as of 8/17 EDUCATION EDUCATION Introducing Mobile Neurology CME Neurology ® CME is now available in a mobile-optimized version. Mobile Neurology CME helps Neurology journal subscribers maintain competence, gain up-to-date knowledge, and learn about best practices and developing issues in the world’s leading clinical neurology publication. Fulfill your continuing education requirements on the go. Features and Benefits of Mobile Neurology CME Fall Conference Programs Focus on Improving Your Practice’s Bottom Line supported for either mobile or desktop views. Tablets, including iPad, will by default display the mobile version of Neurology CME, but can also display the desktop version if you prefer. In addition, a mobile version of Neurology for smartphones is available that is optimized for small screens, works on a variety of devices, and contains most of the content and features of the online journal. •Convenient, portable way to meet your CME requirements •Newly published CME content is instantly available on your mobile device •Your results sync with My CME in the desktop version •Save your progress if you get interrupted •Instant feedback on quizzes with automatic scoring •See highlighted links to the correct answer in context •Claim credit right on your mobile phone •Print certificates from My CME when you get back to your desk With Neurology CME there is no need to download an app. Simply access Neurology CME from any supported mobile device by going to cme.neurology.org. Supported devices are: iPhone, iPod touch, iPad, and Android devices. Palm OS, Nokia phones, etc., that have web browsers may still access Neurology CME; however, the display of Neurology CME may not be optimized for their screens. Blackberry is supported for newer devices with touchscreens, but older Blackberries are not New Features Also Available in Desktop Neurology CME The updated Neurology online CME Program still provides a convenient way to fulfill your CME requirements including: • Quizzes organized into courses that correspond to one issue • Evaluation of courses (mandated by ACCME) • Outlined learning objectives • Links to highlighted answers in text of article Now we offer the following enhancements: • Better visual integration with neurology.org • Login for personalized browsing of CME courses—see what you haven’t done • Search for CME courses by keyword or title word • Email alerts for new CME courses • New Mobile CME access information • Explicit information on state licensure and ACCME guidelines • Enhanced Help and Instruction links You may access CME courses via the Neurology CME page. Links are also provided on the journal home page, on tables of contents, and on the CME-designated articles themselves. AANnews • September 2011 24 Learn how to cut through the red tape to reduce denials, improve your payments, and increase your practice’s bottom line at the 2011 AAN Fall Conference, set for October 21 through 23 at the Encore at Wynn Las Vegas—a favorite destination of previous Fall Conference attendees. Additional talks will include strategies on avoiding regulatory penalties and insurance denials. This year’s Practice Management Track provides three essential programs that offer an excellent opportunity to bring your staff along for additional training on the latest coding and reimbursement updates, practical advice and applications, and tips and tools for increasing your practice’s efficiency and getting paid what you deserve. Friday, October 21 “The complexities governing the provision of health care today make it impossible for physicians to survive without strong guidance,” said Orly Avitzur, MD, MBA, FAAN, director of the Practice Management 201 course. “It’s simply a matter of survival; neglecting the financial aspects of your business can be simply disastrous. And if you’re thinking of leaving practice and joining a hospital system or large multi-specialty group, as many neurologists are starting to do, it’s important to understand the pitfalls of such alliances and avoid getting the short end of the stick.” Program and Faculty: The Fall Conference’s convenient weekend program is limited to only a few hundred participants, making this an ideal learning environment and providing you the chance to network with colleagues and faculty in an intimate atmosphere. And the conference’s compact, three-day schedule offers a remarkable value for maximizing your training and education budget with minimal impact on your busy schedule. Added Avitzur, “We are very fortunate to have Frank Cohen, MPA, a leading medical practice analyst and consultant, share his expertise on improving business practices this year, and William Henderson, FACMPE, practice administrator and member of the Practice Management & Technology Subcommittee, who recently negotiated a merger.” Register for the full Practice Management Program Track and save 10 percent instantly. Practice Management 101: Coding, Billing and the Document—A CaseBased Approach 8:00 a.m.–12:00 p.m. CME Credits: 3.5 hours Director: Bruce H. Cohen, MD, FAAN, Akron, OH •The Basics of E/M CPT / Bruce H. Cohen, MD, FAAN, Akron, OH •Electronic Communication / Neil A. Busis, MD, FAAN, Pittsburgh, PA •Use AAN Guidelines to Avoid Denials / Gregory L. Barkley, MD, FAAN, Detroit, MI Friday, October 21 Practice Management 201: Practicing in 2012: How to Make Sure You Get Every Dollar 1:00 p.m.–5:00 p.m. CME Credits: 3.5 hours Director: Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY Program and Faculty: •Learn Six Sigma for the Medical Practice; Improving Profits by Improving Processes / Frank Cohen, MPA, Clearwater, FL •Mergers and Other Alliances: How to Avoid Getting the Short End of the Stick / William S. Henderson, FACMPE, Albany, NY •Reduce Insurance Denials: Tips and Best Practices for Getting Paid / Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY •Avoid Penalties: Dollars and Incentives / Neil A. Busis, MD, FAAN, Pittsburgh, PA Orly Avitzur, MD, MBA, FAAN Saturday, October 22 Practice Management 301: Hitting the Jackpot with Practice (Performance) Improvements 1:00 p.m.–5:00 p.m. CME Credits: 3.5 hours Director: Bryan Soronson, CRA, FACMPE, MPA, Baltimore, MD Program and Faculty: •Establishing/Improving Your Compliance Program / Mary McDermott, Baltimore, MD •ICD 10: Are You Ready? / Bryan Soronson, CRA, FACMPE, MPA, Baltimore, MD •Ancillary Growth Strategies for the Neurologist / David Evans, Dallas, TX •Emerging Issues / Faculty Save Even More When You Register By September 27 Register by September 27, 2011, to save on registration and hotel costs. Seating for the Fall Conference is limited, so learn more and register today at www.aan.com/view/fall2011. For more information, contact Amy Nostdahl at [email protected] or (651) 332-8687. The 2011 AAN Fall Conference is an ABPN-approved program for maintenance of certification that is geared toward practitioners, academicians, residents, fellows, practice managers, and office administrators. AANnews • September 2011 25 EDUCATION EDUCATION The AAN Store Comes to Fall Conference Continuum Call for Nominations: Editor-in-Chief If you are planning to attend the Fall Conference, be sure to stop by The AAN Store® booth and pick up the latest wirebound 2011 AAN Pocket Guidelines. The Editorial Search Committee for Continuum: Lifelong Learning in Neurology ® is requesting that AAN members submit the names of eligible candidates for Editor-in-Chief of the Academy’s premier self-study continuing medical education program. Self-nominations or nominations of other AAN members are encouraged. A position description, including requirements, is available at www.aan.com/view/continuumeditor. Cascino, MD, FAAN; Bruce Sigsbee, MD, FAAN; Cynthia L. Comella, MD, FAAN; Robert A. Gross, MD, PhD, FAAN; and Steven P. Ringel, MD, FAAN. The Editor-in-Chief is responsible for publishing six issues of Continuum ® a year. The appointment is six years beginning January 1, 2013, with a six-month transition with the current editor beginning July 2012. The Editorial Search Committee members are Robert C. Griggs, MD, FAAN, chair; Terrence L. For more information, contact Andrea Weiss at [email protected] or (651) 695-2742. Other popular items include Ultimate Review for the Neurology Boards: Question and Answer Companion, a handy new supplement to the popular preparatory guide. The new 2012 ICD-9-CM provides the latest coding updates. If you have registered for the conference’s Dystonia Workshop, you will want to get a copy of the latest Manual of Botulinum Toxin Therapy for your convenient reference. Save yourself shipping costs and visit the store to take home the best tools and resources for your practice. All items are available at the AAN member discounted price. Learn more about the AAN Fall Conference at www.aan.com/view/2011fall. Please submit current curriculum vitae with a letter outlining scientific editing experience, a vision for Continuum’s role within the AAN, and an editorial vision for Continuum by November 30, 2011. All candidates will be required to complete an AAN conflicts of interest disclosure. Submit nominations to: Missy Render, AAN Enterprises, Inc., 1080 Montreal Avenue, St. Paul, MN, 55116 OTHER NEWS Two-day Evidence-based Medicine Training Program Now Provides CME The AAN is again offering its comprehensive Evidence-based Medicine Toolkit training seminar for neurology program directors to enable them to establish evidence-based medicine resident education programs at their institutions. And the Academy—one of the leaders in the development and promotion of evidence-based clinical guidelines—is encouraging practicing neurologists and other medical educators to learn how they can put the principles of evidence-based medicine to work in their practices or physician training programs. •Day 2 is split into three breakout sessions designed to provide more in-depth understanding in each of three areas: Analytic Techniques, Clinical Trials, and Theory and Practice. Each breakout session will be comprised of three modules, and each session will be presented in the morning and again in the afternoon. For the first time, the Evidence-based Medicine (EBM) Toolkit training will provide continuing medical education credits. The EBM Toolkit training will take place on October 14 and 15 in Washington, DC, and the two-day session is worth 13 CME credits. The opportunity to earn CME credits, and the flexible structure of the Gary Gronseth, MD, FAAN program, adds considerable value to this training. Attendees can attend one or two days, and receive eight credits for the first day and five credits for the second. More than 50 percent of US neurology program directors have experienced the EBM Toolkit training, which provides all the resources necessary for teaching a comprehensive EBM program. It consists of 19 didactic modules with illustrative examples, outcomes testing for determining learning, and an appendix of calculators of tools. The training demonstrates completion of ACGME core competencies. AAN staff and the EBM expert faculty are available to provide follow-up and assistance to help implement the program. Although the course was developed for resident education, the learning material is appropriate for anyone in a neurologyrelated field. This EBM training also is valuable for program directors, department chairs, and medical statisticians in psychiatry and neurosurgery—as well as educators at medical schools or teaching hospitals, and AAN members are urged to encourage their colleagues in these areas to attend. “The Evidence-based Medicine Toolkit enables neurologists to combine current best practices with new research to provide the best patient care,” said Gary Gronseth, MD, FAAN, the Academy’s evidence-based medicine consultant. “It is difficult to imagine a more essential skill set for effectively practicing medicine.” Registration is free for AAN member program directors and $600 for other AAN members. The fee for nonmembers is $750. Registration for the training is open until September 30. Meals will be provided during the sessions. Travel and lodging are the responsibility of the attendee. The program is structured to accommodate participants’ training needs: To register, visit www.aan.com/education/ebm. For more information about the EBM Toolkit or training, contact Rebecca Penfold Murray at [email protected] or (651) 695-2735. •Day 1 provides training on the 10 core modules that encompass all the basic concepts of EBM and can be easily presented in the course of an academic year. AANnews • September 2011 26 UCNS Practice Tracks in Headache Medicine and Behavioral Neurology & Neuropsychiatry Set to Expire in 2012 The last chance to apply for Headache Medicine or Behavioral Neurology & Neuropsychiatry certification from the United Council for Neurologic Subspecialties (UCNS) without graduating from a UCNS-accredited fellowship program is 2012. exam will be offered the week of October 1 through 5. The application deadline for the Behavioral Neurology & Neuropsychiatry is May 15; the exam will be offered the week of November 5 through 9. Initially, physicians applying for UCNS certification examinations are able to apply using one of two eligibility pathways. The first is graduation from a UCNS-accredited fellowship program. The second is via the practice track, which allows physicians who started with the subspecialty prior to the availability of accredited training programs to qualify for the examination by meeting a defined series of criteria. Beginning in 2014, only physicians graduating from UCNSaccredited training programs in these subspecialties will be eligible to apply for these exams. The exams offered in 2012 for Headache Medicine and Behavioral Neurology & Neuropsychiatry will be the final exams for which a physician may apply using the practice track. Applications will be available in early 2012. The application deadline for the Headache Medicine exam is April 16; the Get Your Daily Dose of Academy and Neurology News at AAN.COM For more information, visit www.ucns.org or contact Todd Bulson at [email protected] or (651) 695-2813. FOCUS ON PRACTICE FOCUS ON PRACTICE New ICD-9 Codes Affect Neurologists Beginning October 1 Neurologists should prepare for new ICD-9-CM codes that will go into effect October 1, 2011. There are several new codes listed below that will affect neurology, particularly with regard to headache and migraine, dementia, and epilepsy. and ICD-10 code sets to capture new technology and new diseases. “There will be no further changes to ICD-9-CM diagnosis codes except for new diseases with public health implications,” said Powers. “After the October 1, 2011, update to ICD-10-CM, there also “The changes to ICD-9-CM beginning October 1 will be a hold on any changes to that classification reflect to some extent the changes the AAN has until October 1, 2014. We at the AAN have worked been seeking for ICD-10-CM with the assistance diligently at tweaking ICD-10-CM before the of AAN sections and neurology subspecialty upcoming October 1 freeze, as that is the version organizations,” said Laura B. Powers, MD, FAAN. of the classification that will replace ICD-9-CM on “In addition to a specific code for brain death, we Laura B. Powers, MD, FAAN October 1, 2013. With both classifications ‘frozen,’ also have a new code for corticobasal degeneration. we at the AAN can concentrate on getting the The codes for Lambert-Eaton syndrome have membership ready for ICD-10-CM implementation in 2013.” been changed to reflect those not associated with neoplasm. ‘Refractory’ is now officially synonymous with ‘intractable’ in the fifth digits for migraine codes.” A major victory for neurology was the revision to the title of Chapter 5 from “Mental Disorders” to “Mental, Behavioral and Neurodevelopmental Disorders.” This is a considerable change that will bring more awareness that diagnoses such as dementia are not “mental disorders” but rather neurologic diseases with organic causes. This is the last regular, annual update to both ICD-9-CM and ICD-10-CM. There will be what is considered “a partial code freeze” until the implementation of ICD-10 on October 1, 2013. Until that time, there will be only limited code updates to ICD-9 For more information, contact Luana Ciccarelli at [email protected] or (651) 695-2779. November AAN Webinar to Explain Transition to ICD-10 “ICD-10: What You Need to Know for 2012,” set for November 8, will help demystify the upcoming changes to the ubiquitous coding manual. Participants will learn to choose the appropriate diagnosis code for a service, become aware of the mechanics of the system and its updates, begin preparing for ICD-10-CM implementation, and identify the differences between ICD-9-CM and ICD-10-CM. Visit www.aan.com/go/practice/coding/conferences to learn more. New subcategory 294.2 Dementia, unspecified Excludes: mild memory disturbances, not amounting to dementia (310.89) New code 294.20Dementia, unspecified, without behavioral disturbance Dementia NOS New code 294.21 Dementia, unspecified, with behavioral disturbance Aggressive behavior Combative behavior Violent behavior Use additional code, where applicable, to identify: wandering in conditions classified elsewhere (V40.31) New code 310.81 Pseudobulbar affect Involuntary emotional expression disorder Code first underlying cause, if known, such as: Amyotrophic lateral sclerosis (335.20) Late effect of cerebrovascular accident (438.89) Late effect of traumatic brain injury (907.0) Multiple sclerosis (340) New code 310.89 Other specified nonpsychotic mental disorders following organic brain damage Mild memory disturbance Other focal (partial) organic psychosyndromes Postencephalitic syndrome Excludes: memory loss of unknown cause (780.93) 346Migraine The following fifth-digit subclassification is for use with category 346: 0 without mention of intractable migraine without mention of status migrainosus New (without mention of refractory migraine without mention of status migrainosus) 1 with intractable migraine, so stated, without mention of status migrainosus New (with refractory migraine, so stated, without mention of status migrainosus) 2 without mention of intractable migraine with status migrainosus New (without mention of refractory migraine with status migrainosus) 3 with intractable migraine, so stated, with status migrainosus New (with refractory migraine, so stated, with status migrainosus) Also of importance is the new code to be used for Brain Death: New Code 348.82 Brain Death AANnews • September 2011 28 Proposed 2012 Medicare Physician Fee Schedule Includes AAN Quality Measures The proposed Medicare Physician Fee Schedule (MPFS) for 2012 issued by the Centers for Medicare & Medicaid Services (CMS) in July includes quality measures developed by the AAN for epilepsy, dementia, and Parkinson’s disease. proposes that the AMA Relative Value Update Committee (RUC) investigate whether evaluation and management (E/M) codes as well as the highest volume and dollar procedural codes billed by physicians are appropriately valued. “The AAN worked hard to ensure these measures were added to the program and will urge CMS to adopt their proposed inclusion of the measures as final for 2012,” said Neil A. Busis, MD, FAAN, chair of the AAN’s Medical Economics and Management Committee. “The addition of the measures into the program will give neurologists the best opportunity to participate.” The AAN is working diligently to move broader payment and policy discussion towards recognition and appropriate valuation of cognitive services (E/M) over procedural care. The MPFS, which also updates payment policies and rates for physicians and non-physician practitioners, reflects current law under which providers would face steep across-the-board reduction in payment rates, based on the flawed Sustainable Growth Rate (SGR). If Congress does not act this year to suspend the reduction, Medicare payment rates are expected to decrease by 29.5 percent in 2012. “The AAN feels the SGR is flawed in many ways and needs to be replaced,” said Busis. “Congress is looking to physicians and specialty societies for ideas on how to fix the flawed SGR. The AAN has provided initial thoughts to policymakers and continues to work to develop a fair and workable solution to this well-recognized problem.” In a statement released by CMS Administrator Donald M. Berwick, MD, said, “This payment cut would have serious consequences and we cannot and will not allow it to happen. We need a permanent SGR fix to solve this problem once and for all. That’s why the president’s budget and his fiscal framework call for averting these cuts and why we are determined to pass and implement a permanent and sustainable fix.” In an effort to ensure Medicare is paying accurately for physician services and more closely managing the payment system, CMS CMS is also proposing: •To expand its multiple procedure payment reduction to the professional interpretation of advance imaging services to account for overlapping activities that go into valuing these services. • Criteria for a health risk assessment (HRA) to be used in conjunction with Annual Wellness Visits (AWVs), for which coverage began January 1, 2011, under the Affordable Care Act. •To change the way services are added to the approved telehealth list that would allow requestors to provide evidence of the clinical benefit of the service. •To update a number of current physician incentive programs such as the Physician Quality Reporting System (PQRS), the e-Prescribing Incentive Program and the Electronic Health Records Incentive Program. CMS also proposes quality and cost measures that the agency would use in establishing a new value-based modifier to reward physicians for providing higher quality and more cost-efficient care. More than 1 million providers of vital health services to Medicare beneficiaries are paid under the MPFS. CMS projects that total payments under the MPFS in CY 2012 will be $80 billion. CMS accepted public comments up to August 30, and will review and respond to all comments in a final rule to be issued around November 1, 2011. Key Deadline Nears for EHR Incentive Program Practicing neurologists only have one month left to register for the 2011 Medicare Electronic Health Record (EHR) Incentive Program. Through successful reporting over a five-year period, neurologists using a qualified EHR are eligible for up to $44,000 through the Medicare incentive program. “There is no doubt that the practice of medicine is going to require the use of electronic health records as we go forward,” said Steven J. Zuckerman, MD, FAAN. “While the implementation process will inevitably present some challenges (like any changes to a comfortable routine) the results are gratifying in regards to improving care. Adopting an EHR and demonstrating Meaningful Use is a process that all physicians will need to accomplish. Proving adherence to the regulations by attestation this year is a relatively easy process. Why not bite the bullet now and have three months of use count as an entire year for incentive monies— worth upwards of $18,000. This will be the only window of opportunity for such a good deal with government reimbursement.” Visit www.aan.com/go/practice/pay/ehr to learn more about the program and access important resources and tools, including ratings of vendors and EHR systems provided by the AAN’s new partnership with AmericanEHR Partners. Steven J. Zuckerman, MD, FAAN AANnews • September 2011 29 FOCUS ON PRACTICE MEMBERSHIP Registration Ends September 16 for New Webinar on Negotiating with Hospitals and Insurers Negotiating with hospitals and insurers can be a touchy topic. The latest AAN Practice Management webinar “Win, Lose, or Draw? Negotiating with Hospitals and Insurers,” helps members understand the pitfalls and gives expert advice to prepare for this sometimes challenging area of practice. The 90-minute webinar scheduled for Tuesday, September 20, at 12:00 p.m. ET provides physicians 1.5 AMA PRA Category 1 Credits™, and nonneurologists receive a certificate of completion redeemable for credits. The deadline to register is September 16. for a negotiation. We also will discuss how to conduct a negotiation.” In addition, the program will teach participants how to use the AAN’s Insurer Relations Toolkit and other valuable resources to manage the negotiating process. Kaufman is chair of the AAN’s Payment Policy Subcommittee and a member of the Medical Economics and Management Committee. “Negotiating is difficult for some individuals as they do not have a process to prepare and present to the Joel M. Kaufman, MD, FAAN other side,” said Kaufman. “Physicians, in particular, do not seem to take the modest amount of time Program Director Joel M. Kaufman, MD, FAAN, will help to build their case or develop a long-term strategy to achieve participants understand how to effectively negotiate with their goals. This webinar will give some practical tools that will private insurers and hospital management as well as build build confidence.” and maintain positive and productive relationships with these Registration ends soon; visit www.aan.com/go/practice/coding/ insurers and hospitals. conferences to sign up now. Members save on remaining “The biggest risk of not being prepared is leaving money on webinars in the series when they sign up for more than one the table or not receiving benefits for work or effort that you using their member discount. are already doing,” said Kaufman. “Webinar attendees will learn For more information, contact Christi Kokaisel at more about what to do, rather than what to avoid. Preparation is key, and we will review several approaches on how to prepare [email protected] or (651) 695-2810. Neurology Career Week Brings Job Opportunities, Resources to Members Residents, fellows, graduate students, and anyone looking to make a career change are encouraged to participate in Neurology Career Week, a new online event October 10 through 14. This exclusive AAN event is the only career fair specific to neurologists and neurology-related positions. The event is free for members who can participate by creating an online profile in the Neurology Career Center at www.aan.com/careers. Visit the website for the latest details and current week’s schedule. Activities for the week include: •Online Job Fair—Visit virtual booths and chat with an array of employers seeking neurologists •CV Reviews—Submit your curriculum vitae before October 11 to be reviewed by experienced AAN members who can give you feedback on how to improve your résumé •Mock Interviews—Schedule a face-to-face video interview via Skype to practice your interview skills and get advice on presenting yourself during a real interview, email [email protected] by October 7 •Daily AAN Store Specials—Each day a new item from the AAN Store will be offered at a special rate in addition to your member discount •Online Job Search—Look for your next career opportunity on the world’s largest job search site for neurologists Olson to Be Honored by AMA Former AAN President Sandra F. Olson, MD, FAAN, will be presented with the Distinguished Service Award by the American Medical Association during the opening session at its Interim Meeting on Saturday, November 10 through 12, 2011, in New Orleans. According to the AMA, the Distinguished Service Award is bestowed upon AMA members for meritorious service in the science and art of medicine. “I feel very honored by this award,” said Olson, “and I wish to thank the Academy for supporting my nomination for it. I have always found participation in medical society activities rewarding, fulfilling, and downright fun.” Learn about these exciting events for job seekers by visiting www.aan.com/careers today. Olson served as AAN president from 2003 to 2005 and is the first—and only—woman to hold this position in the Academy. She also was the first woman to chair the AAN Foundation, serving from 1999 to 2000. She also served on the AAN Board of Directors and numerous Academy committees. She has been active in many other organizations including the Accreditation Council for Graduate Medical Education, the American Medical Association Council on Medical Education, the Illinois State Medical Society where she served as president from 1996 to 1997, and the Chicago Medical Society where she was president from 1993 to 1994. She was a longtime attending physician with Northwestern Memorial Hospital in Chicago and professor of clinical neurology at Feinberg Medical School of Northwestern University. Residents, fellows, and post-doctoral graduates are encouraged to prepare in advance for Neurology Career Week. Here are a few tips: 1. You must be an AAN member to create a free Career Center profile. If you are not yet a member, visit www.aan.com/go/ membership/join or talk with your program director. 2. Polish your CV and send it to www.aan.com/careers before October 11 to be reviewed by an experienced AAN member. 3. Mark your calendar for the week of October 10 so you can make the most of your time garnering advice, meeting potential employers, and searching for jobs online. In addition, Neurology Career Week will also host four free webinars for neurology professionals, including: •Monday: “Transition from J1-Visa to Working Visa,” for international physicians •Tuesday: PRMS Risk Management Services, Inc., will provide a comprehensive overview of risk management for residents and fellows entering the field •Wednesday: Hospital Corporation of America explain how the HCA stipend program works, a one- to two-year career opportunity for residents •Thursday: “Employment Contracts: What You Should Know” will offer solid advice for job seekers negotiating their first contract MEMBERSHIP Career Checklist for Neurology Trainees Win Prizes When You Create Your Career Center Profile Visit the Career Center during Neurology Career Week and you could win an iPad 2 or a Resident & Fellow Career Kit which includes a Queen Square Hammer, Lanska edition; a 2011 AAN Pocket Guidelines, and an Ultimate Review for the Neurology Boards book. All profiles created or updated between September 1 and October 14, 2011, are automatically entered and eligible to win! Sandra F. Olson, MD, FAAN Call for Volunteers for Neurology’s Abstract Translation Project In order to provide readers worldwide with information about articles in Neurology ®, the journal soon will begin publishing translations of abstracts in multiple languages. Neurology is seeking volunteers, including translators and reviewers of translations, to assist with this new abstract translation project. Each abstract translation will be attributed to the translator and be indexed along with the main journal article on the neurology.org website. Translated abstracts will be accessible as a link to the online article and also available in language-specific online collections. To volunteer for this project or for more information, visit www.neurology.org or contact Lee Ann Kleffman at [email protected] or (651) 695-2782. AANnews • September 2011 30 AANnews • September 2011 31 MEMBERSHIP FOUNDATION New Recruitment Concierge Service Assists in Finding Job Candidates Foundation Friends With many practices struggling to fill positions—that can take more than a year to recruit—the AAN’s Neurology Career Center now offers a new job candidate review service to help streamline the process for busy practices of all sizes. The Recruitment Concierge Service handles the bulk of the workload by writing an advertisement based on your criteria, responding to inquiries and reviewing resumes. The AAN Foundation greatly appreciates gifts and pledges received from the following donors between June 1 and June 30, 2011. Cumulative annual gifts and pledges of $1,000 or more are recognized as Champions Circle members, and gifts and pledges of $100 and greater are recognized as Foundation Friends in AANnews ®. You have the option of choosing from a variety of online and print advertising options. For secure online giving options, visit www.aan.com/foundation/donations. For more information about the AAN Foundation programs, contact Susan C. Dunlop at [email protected] or (866) 770-7570 Ext. 2701. The concierge is a vetted service partnering with the Academy that is knowledgeable in hiring the best qualified candidates for the job. As a member-only benefit you can put the service to work in filling your practice’s open positions for only $1,500, where a comparable service will usually start around three times as much. The fee is flat and no commission is involved. “I am proud to join with the AAN Foundation to support research addressing the striking disparities in neurological disease burden among minority populations. Once again, the Foundation is making it possible for gifted neurology trainees and those just out of training to dedicate themselves to critically needed research. The Calvin Calhoun, Sr., MD, Minority Scholars Diversity Research endowment is a high impact initiative which will create new knowledge in stroke and other neurologic diseases with disparate risks, characteristics, and outcomes in the minority communities they afflict.” For more information, visit the Neurology Career Center at www.aan.com/careers or contact Amy Schoch at [email protected] or (651) 695-2749. New AAN Headquarters Site Gets Visit from Obama Administrator The building site of the new AAN headquarters in Minneapolis received a visit from a representative of the Obama administration on August 8. Frank P. DiGiammarino III, Director for Recovery Implementation for the White House, examined the steel framework and fresh concrete floors of the five-story building with AAN Executive Director Catherine M. Rydell, CAE; Chief Finance Officer Tim Engel; and executives from Mortenson Construction, the contractor for the project. DiGiammarino has been on a nationwide tour of building projects that have benefitted from bonds funded through the American Recovery and Reinvestment Act of 2009. The total cost of the AAN project including land, building construction, office furniture, and professional fees are $20 million. The Academy’s new building was funded using $15 million in City of Minneapolis Recovery Zone Facility Bonds, which are designed to encourage capital investment and are funded through the American Recovery and Reinvestment Act of 2009. The balance was provided from Academy reserves. The AAN Board of Directors took steps to set aside annual operating reserves over the last five years to support the ownership of a building for the current staff and programs and to better serve the future growth of the Academy. Dawn McGuire, MD, FAAN AAN Member since 1995 Annual Fund ($1,000–$4,999) Steven L. Lewis, MD, FAAN+* John C. Morris, MD, FAAN+* John G. Nutt, MD, FAAN+* Executive Director Catherine M. Rydell, CAE, greeted Frank P. DiGiammarino III at the building site. ($500–$999) Gregory L. Barkley, MD+ Lisa M. DeAngelis, MD, FAAN+ Stanley Fahn, MD, FAAN+ Edward J. Fox, MD, PhD, FAAN+ J. Clay Goodman, MD, FAAN+* Daniel B. Hier, MD, MBA, FAAN+ Janice M. Massey, MD, FAAN+ Suzanne Powell, MD+ Kapil D. Sethi, MD, FRCP (UK), FAAN+ S.H. Subramony, MBBS, FAAN+ ($100–$499) Michael E. Batipps, MD, FAAN Patricia S. Cook, MD, FAAN Edward S. Cooper, MD Deborah I. Friedman, MD, FAAN+ Robert C. Galbraith, MD Victor W. Henderson, MD, FAAN+ Peter B. Kang, MD+ Jayne Ness, MD+ Joseph E. Safdieh, MD+ Frederick J. Samaha, MD, FAAN Adeline Vanderver, MD+ Bradley V. Vaughn, MD, FAAN+ David Graham with ESG Architects, Inc. (left) joined Rydell and DiGiammarino on the fourth floor of the structure. In the background are a section of the historic grain mills and the blue-clad Guthrie Theater, with the Mississippi River behind them. The building from the front corner. The Hubert H. Humphrey Metrodome can be seen a few blocks away. AANnews • September 2011 32 The Fund For Brain Research Provides Clinical Research Training Fellowships to the Most Qualified Applicants ($500–$999) Anonymous* Jasper R. Daube, MD, FAAN+ J. Clay Goodman, MD, FAAN+ Anthony E. Lang, MD, FAAN+ John M. Pellock, MD, FAAN+ ($100–$499) Anonymous Arthur K. Asbury, MD, FAAN (In memory of Raymond D. Adams, MD) Edward Feldmann, MD+ Omar A. Khan, MD, PhD+ Aaron E. Miller, MD, FAAN+ John C. Morgan, MD, PhD+ Jayne Ness, MD+ AAN Residents Fund ($1,000–$4,999) Jóse Biller, MD, FAAN, FACP, FAHA+* Cynthia L. Comella, MD, FAAN+* Aaron E. Miller, MD, FAAN+* ($500–$999) Konstantin E. Balashov, MD, PhD+ Nicolaas I. Bohnen, MD, PhD+ John Corboy, MD, FAAN+ Robert J. Fox, MD, FAAN+ Mark W. Green, MD+ Dara G. Jamieson, MD+ Ralph F. Józefowicz, MD, FAAN+ Jaffar Khan, MD+ James B. Leverenz, MD+ Ann N. Poncelet, MD+ Bryan E. Tsao, MD+ Elaine C. Wirrell, MD+ ($100–$499) Charles H. Adler, MD, PhD, FAAN+ James Y. Garbern, MD, FAAN+ Christopher Glisson, DO+ Mark Keegan, MD+ Coleman Martin, MD+ Jayne Ness, MD+ C. Warren Olanow, MD, FAAN+ Gerald Raymond, MD+ Joseph E. Safdieh, MD+ Nancy L. Sicotte, MD, FAAN+ Scott S. Zamvil, MD, PhD, FAAN+ Alzheimer’s Research Fund ($500–$999) Anonymous* MS Research Fund ($100–$499) John W. Rose, MD, FAAN Neuro-Infectious Disease Research ($500–$999) Russell E. Bartt, MD, FAAN+ Avindra Nath, MBBS, FAAN+ Calvin L. Calhoun, Sr., MD, Minority Scholars Disparity Research Permanent Endowment ($1,000–$4,999) Charles C. Flippen II, MD, FAAN* Edgar J. Kenton III, MD, FAAN* Dawn McGuire, MD, FAAN* ($100–$499) John and Susan Dunlop, MBA, CFRE * Denotes 2011 Champions Circle member + Denotes Honoraria Donor AANnews • September 2011 33 Formerly: Visit the AAN’s new Neurology Career Center online at www.aan.com/careers for additional job postings and to sign up for customized, confidential notifications when new positions of interest are added. www.aan.com/careers Physician-Owned Multi-Specialty Group near Boulder, Colorado Longmont Clinic, a physician-owned multi-specialty group with more than 50 physicians representing 20 specialties, is seeking two General Neurologists. This is an outstanding quality of life opportunity that will allow you build a thriving neurology practice. You will be employed by Longmont Clinic and will practice at a state-of-the-art, 183-bed community hospital, which resembles a world class hotel. Longmont, Colorado, located within Boulder County, is known as the gateway to Rocky Mountain National Park. With a population of over 85,000 and a medical service area of over 350,000, this community offers more than 300 days of sunshine, spectacular views of the Rocky Mountains, outstanding schools and state-of-the-art health care. Contact Kim DeBlasi at (800) 678-7858 x64558; [email protected]; or visit www.cejkasearch.com. ID#134904DE. Neurologist Altru Health System located in Grand Forks, North Dakota is a physician led, not-for-profit, 277-bed integrated health system. More than 180 physicians representing 44 specialties serve Altru’s referral population which exceeds 225,000 people. Altru’s affiliation with the University of North Dakota School of Medicine allows our physicians exposure to teaching opportunities. We are a Level II Trauma Center designation. Grand Forks is a Midwestern community of 65,000. Besides the warm friendliness of its residents, you will find excellent school systems, safe neighborhoods, low crime rates, affordable housing and an abundance of cultural and recreational activities. Premiere neuroscience group in the region guaranteeing a busy practice with interesting pathology. Full EEG and EMG services provided. Multiple Sclerosis Specialty Clinic on-site. Pediatric work available. Committed team of 3 Neurologists and 2 mid-levels. Jenny Semling, Physician Recruiter, Altru Health System, (800) 437-5373 ext 6607; Fax: (701) 780-6641. [email protected] General Adult Neurology Hospitalist - CT and MR reading privileges Anderson, South Carolina. BC/BE adult neurologist for in-house coverage week days for consults and ED call for acute stroke and intraparenchymal bleeds. A neuro-intensive specialist with interest in stroke is important; medical director needed. Employment model with competitive RVU-based compensation; generous benefits including malpractice and CME allowance. CT and MRI reading privileges. 461-bed medical center of 578-bed AnMed Health System. NICU and 45-bed rehab hospital. Stroke Center of Excellence. One medical-system city serves an area approaching 400K. Level two trauma center; local hospitalist group; FM residency; cancer center; heart and vascular center. Anderson is on 50,000-acre Lake Hartwell and I-85, thirty miles from Greenville. Only two hours to Charlotte, Atlanta or Columbia. And a morning`s drive to Charleston. Email [email protected] Neurologist (MS Specialist) - Charlotte NC The Neurology Department at CMC is seeking a Neurologist, specializing in MS to join their high caliber team of faculty providers and well-known MS Center. Qualified candidates will be BC/BE in Neurology with extensive experience in treating MS. Ideal candidates will be ACGME fellowship trained in MS and have an interest in education and research. The MS Center offers state-of-the-art resources along with an active clinical research program supported by 10 research coordinators and assistants. The clinical staff includes on-site nurses, physical therapists, occupational therapists, speech therapists, social workers and a dietician. CMC Neurology offers an attractive hybrid model of private practice and academics. The Neurology faculty has the flexibility to see patients in physically attractive clinic, teach residents and medical students, and participate in clinical research. The MS Center is situated near uptown Charlotte in a beautiful residential area. Carolinas HealthCare System (CHS) is a not-for-profit, self-supporting public organization. It is the largest healthcare system in the Carolinas, and one of the largest public systems in the nation. Charlotte, NC is a growing and vibrant city and is 2 hours from the mountains of NC and 3-4 hours from the beaches of NC and SC. To send a CV for consideration, please contact: Tracey Black, Physician Recruiter, P (704) 355-0159/ (800) 847-5084; [email protected] BC/BE Neurologists Upstate New York - Adirondack Mountains – Lake Champlain Region. CVPH Medical Center (www.cvph.org) seeks two BC/BE neurologists to join its medical staff. Candidates with a particular interest in stroke medicine is a plus. Enjoy being a hospital employee with a comprehensive benefit package and call of 1:3. Competitive salary with productivity incentive, sign-on and loan repayment. Big hospital, small city on Lake Champlain, near the Adirondack Mountains, the Olympic-Lake Placid region, Burlington, VT, and Montreal. Contact: Rebecca Larkin ([email protected]) 75 Beekman St., Plattsburgh, New York 12901, (518) 314-3025, Fax: (518) 562-7012 Neurologist Dean Clinic, a 450+ physician-owned multi-specialty group, is seeking a general Neurologist. A strong interest and expertise in EMG is required. A fellowship in Neurophysiology is ideal, but not required. Call is shared with all of the Neurologists in the Department and is thus 1/10. The position is based in Madison, but all Neurologists do six outreach clinic days per month throughout the Dean system. The Department of Neurology is located in a medical office building that is connected to St. Mary's Hospital, a 350-bed tertiary care facility. There is a guaranteed two-year salary and signing bonus, plus an outstanding fringe benefits package. This is a shareholder track position and shareholdership is available after two years. Email [email protected] Neurology in Atlanta, Georgia Atlanta, Georgia neurology. Our three facility system is in the process of expanding its neurology services by adding a new physician. Join existing hospital employed practice, full practice from day one. 1-7 phone call, (4 nights a month). Once again hospital Employed position. Current practice has the majority of the market in our part of Atlanta proper, EMG/nerve conduction on site, Hospitalist does admits thru the ERs, some nerve blocks and carpel tunnel injections, interest in stroke is a plus, EEG's in the hospital. Atlanta is home to the busiest airport in the world. Birthplace of Martin Luther King Jr., and the civil rights movement. Headquarters for Delta Airlines, Coke, CNN, TBS, Holiday Inn, UPS, Johnson products. Atlanta Hawks, Braves Falcons, pro sports. Give me a call for all the details. Phone: (404) 816-1801. Employer will assist with relocation costs. General Neurologist NYU New York City, midtown, private practice with a neurologist and three physiatrists. Requiring to join NYU faculty and applying privilege at NYU medical center. Out patients care, preferring having experience of treatment for Parkinson’s disease, pain management and general neurologic out patient care, including EEG, EMG, VNG, sleep specialty plus. No partnership available, start with salary ($160K) with late bonus production, benefit including two week vacation, one week paid CME, health insurance and 401K. Email [email protected] Neurology Opening in Central Massachusetts Opportunity for a BE/BC Neurologist to join Fallon Clinic’s group of 5 Neurologists and 1 NP. Office hours are Monday - Friday with 1:6 call on weekends and 8-9 weeks/year for inpatient weekday call. On average 12-20 patients are seen a day. Some teaching responsibility. Interest in Multiple Sclerosis and/or Carotid Ultrasonography is a plus. Competitive compensation and benefits. Fallon Clinic leads central Massachusetts in quality of care, consistently scoring above average on the Massachusetts Quality Health Partners quality report. For more information or to apply, contact Jennifer Sonneland at (800) 562-9034 or [email protected]. Neurologist First Coast Cardiovascular Institute is adding neurologists to help it fulfill its mission of serving the cardiovascular needs of the residents of the greater Jacksonville and St. Augustine, Florida area. The diverse group is currently made up of cardiology and vascular specialists including non- invasive, two neurologists, a sleep neurologist, invasive, electrophysiology and coronary and peripheral vascular interventionalists, carotid interventionalists and looking to add a neurologist to our private group. This position will most likely be based in St. Augustine and Palatka, Florida. We are seeking a neurologist who can join this very busy practice. In addition to general neurology, the ideal candidate will be able to contribute immediately to some or all of the many hospital and clinic based services including stroke management. The group has its own fully accredited cath lab, digital echocardiography labs, non-invasive accredited vascular labs with RVTs on staff, accredited nuclear medicine, sleep lab, venous clinic and research departments. The northeast Florida coast area is known for its historic and natural beauty and provides all of the amenities of a large city along with the benefits of living in small close knit communities. In addition to the many cultural attractions this area has year round mild temperatures, affordable housing and top rated schools. This is a very rewarding partnership track opportunity for the right candidate to join a group of well-respected colleagues who work well as a team. Reasonable call schedule, competitive salary and benefits. Email [email protected] Neurologist – Tacoma, WA Group Health Physicians, the Pacific Northwest’s premier multi-specialty group, is currently seeking BC/BE Neurologist to join our Tacoma Medical Center. The ideal candidate(s) for this outpatient only opportunity will have a MS/Behavioral Neurology Fellowship and an interest in an innovative group practice. Competitive salaries and generous benefit packages are offered. Flexible schedules and outstanding teams make this opportunity worth exploring. For additional information or to submit your CV, please contact: Jenelle Van Assen, [email protected]. GHP Recruiting. (800) 543-9323 Pediatric Neurologist The Section of Pediatric Neurology at Children’s Hospital at Dartmouth is adding another Pediatric Neurologist. We seek a Board certified/eligible motivated neurologist who has general and clinical pediatric neurology skills with a strong interest in teaching. Subspecialty skills or research interests are encouraged and will be supported. There is also potential opportunity to engage in regional development. The position includes appointment to the faculty of the Department of Pediatrics and Dartmouth Medical School at a rank commensurate with experience and academic portfolio. Currently, our section consists of several talented, dedicated individuals who enjoy living and working in a beautiful rural setting with all the benefits of a top-notch academic medical center and nearby Dartmouth College. Full-time preferred but part-time interest considered. The Upper Valley is ranked highly as a desirable place to live and work with wonderful recreational and cultural opportunities, proximity to Boston and Montreal and excellent local schools. Interested candidates should send their CV’s and Letters of inquiry electronically to: Richard P. Morse, MD, Chief of Child Neurology and Development, Children's Hospital at Dartmouth, DartmouthHitchcock Medical Center, [email protected]. Dartmouth-Hitchcock Clinic is an affirmative action/equal opportunity employer and is especially interested in identifying female and minority candidates. www.Dartmouth-Hitchcock.org General Neurologist: Western Wisconsin Nestled near the Wisconsin/Minnesota border, the beautiful western WI communities of Hudson and New Richmond boast newly remodeled hospitals, excellent nursing and clinic support staff, and a strong and fast-growing patient base. Qualified, experienced BC'd candidates will have an entrepreneurial spirit and desire to practice communitybased general neurology, while benefiting from the stability, support and camaraderie of our larger Neurology group in nearby St. Paul, MN. An exciting, rewarding practice, a highly competitive benefits and comp package, paid malpractice, and great colleagues await. Forward your CV and cover letter to [email protected] or apply online at www.healthpartners.jobs. EOE. HealthPartners Medical Group; healthpartners.com The Clinical Neurophysiology Fellowship Opening The Department of Neurology at Henry Ford Hospital is offering two positions for fellows in EEG track and one position in EMG track of Clinical Neurophysiology Fellowship beginning July 2012. This is a one-year ACGME accredited fellowship that provides an extensive training in Clinical Neurophysiology. We offer five positions every year. On completion of the fellowship, the fellows gather far-reaching skills in more than one of the following: EEG, video/EEG monitoring, critical care monitoring (CCM), magnetoencephalography (MEG), evoked potential (EP) studies, sleep studies, EMG/ neuromuscular AANnews • September 2011 34 training including Botox injections, muscle/nerve biopsies and autonomic function test. Fellows are required to participate in clinical research project. Candidates should send their CV, letter of interest and 3 letters of recommendations to: Terry Bell (Fellowship Coordinator), Department of Neurology (K-11), 2799, W. Grand Blvd, Henry Ford Hospital, Detroit, MI 48202. Phone: (313) 916-7205. Fax: (313) 916-5117 Neurointensivist needed in Sacramento, CA Mercy Medical Group is a multi-specialty group with more than 260 healthcare providers in the Sacramento, CA region and is the premier provider of Neurology services in the area. We are seeking a BC Neurologist with fellowship training/certification in Neurological Critical Care. The candidate will be a member of our diverse Division of Neurology working within an integrated hospital system with an established Neurointensivist and hospital-based Neurology Program. Strong leadership capabilities and willingness to collaborate with physician leaders, nursing leaders and service-line administrators is required. This candidate will be responsible to help formalize and grow the Neurological Critical Care service for Mercy Neurological Institute of Greater Sacramento to ensure high quality, safe and effective care for patients affected by catastrophic emergent neurological injury and neurological complications in critically ill patients in our Neuro-ICU. This individual will provide service in direct support of the Mercy Neurological Institute of Greater Sacramento at Mercy San Juan Medical Center (www.mercysanjuan.org), a level 2 trauma center, with secondary services at Mercy General Hospital (www.mercygeneral.org), a tertiary level facility for heart and vascular disease. Both facilities are Joint Commission Certified Primary Stroke Centers offering a complete interdisciplinary stroke intervention team including neurosurgeons, neuro-interventional radiology, and bi-plane angio neurointerventional suite Mercy Neurological Institute (www.mercyneuro.org) is a market leader and is actively involved in clinical research trials and consistently setting the community standard for patients affected by neurological diseases. This shareholder track opportunity offers a very competitive compensation and benefits package, including bonus potential and a very desirable retirement plan. Mercy Medical Group (www.mymercymedgroup.org) is a service of CHW Medical Foundation (CHWMF). CHWMF is affiliated with Catholic Healthcare West, one of the leading healthcare systems in the country. For more information, please contact Colin Harris, Sr. Physician Recruiter, at (916) 733-3415 or [email protected]. BC/BE Adult Neurologist A growing, busy, well established practice in South Carolina is seeking a hard working general neurologist. EMG expertise and/or sleep a plus. Other subspecialties welcomed. Join three other experienced neurologists. One in four call, practice owned sleep lab, EEG, EMG and state of the art open bore MRI. Market responsive salary with bonus possible first year. Early partnership, comprehensive benefits and retirement plan provided. Near Charlotte, NC and close proximity to the mountains and beaches. Email: [email protected] Neurologist / Southeast Pennsylvania suburbs Southeast Pennsylvania suburbs. Excellent opportunity for BE/BC Neurologist to join busy 3-person private practice in the SE Pennsylvania suburbs. We have one office and are the primary Neurology group at a community-teaching hospital where we also administer the stroke program. We offer excellent benefits, competitive compensation, potential partnership, and a stimulating and supportive environment. Interested candidates, please E-mail CV to: [email protected] BC/BE Neurologist Looking for a fantastic quality of life with an exciting and challenging new opportunity? Please consider the following opportunity: Seeking a hardworking, reliable and personable BC/BE neurologist to join of a very busy and growing adult neurology and pain management practice in Northern Virginia for expansion of Neurohospitalist/stroke program. Generous 200K starting Salary plus production bonus and benefits. Excellent specialists and ancillary staff for support. Stroke training and/or experience developing a program a plus. Imagine a community where history is alive, cultural offerings is abundant and housing prices are affordable. Northern VA has a dynamic and growing population, with opportunities for each member of the family; please consider this diverse Community located in Woodbridge, VA. With Washington DC only 35 miles away you will be more than satisfied with calling this community home. This community also offers strong local economy, public and private schools with magnet level and college prep courses, major universities and colleges located nearby, first class restaurants, outdoor activities, cultural amenities and a vibrant night life of our Nation’s Capital. Enjoy the Washington DC’s Theatres, Museums, zoo, concerts, professional baseball, football, hockey, basketball and more. Easy access to the Atlantic Beaches. Live nearby in the community or commute from northern Virginia and Washington DC only 35 miles away. We want to talk to you. We will sponsor H-1. Send CV and letter of interest to [email protected]. Neurologist Actively recruiting BC/BE Neurologists to be the 5th or 6th in busy practice on the central east coast of Florida. Benefit from the support and stability of an established practice. Need both a neuro-hospitalist and an office-based neurologist. Full time or part time. Untapped growth potential offering salary with quarterly incentive bonus and opportunity for partnership. Benefits include paid malpractice, health insurance, 401K and CME allowance. Principle hospital is 514 beds with certified stroke center. Small town feel offering camping, biking, fishing, boating, ocean beaches 5 minutes away, space program and great schools. Only 30 minute drive from Orlando, with nearby NBA team, international airport, Disney, and other entertainment/dining activities. Contact Melinda at (321) 984-9400 x3109 or [email protected]. Neurology Position in South Miami, Florida Neurology Opportunity in South Miami, Florida. Seeking a general or sub-specialty trained Neurologist, BC/BE, to join a highly regarded, well-established 5 Physician practice. The office is affiliated with South Miami Hospital, a Baptist Healthcare System hospital that is a Primary Stroke Center enjoying an excellent reputation for quality care. This office is a hospital based office in a modern building, enclosed garage and covered connection to the hospital. Competitive salary and benefit package. This is an excellent opportunity for personal and professional growth. We offer a collegial environment with a strong infrastructure. Interested candidates are invited to send their CV [email protected] Neurologists Well-established, quality oriented neuroscience group seeks to add additional neurologists to our team, including a rehabilitative neurologist, pediatric neurologist, and general neurologist. We are a multidisciplinary neuroscience group providing a strongly collaborative environment and opportunities for professional growth. Our location offers easy access to the cultural institutions of Boston, the mountains, the ocean, as well as outstanding private and public school opportunities for children. Send C.V. to Howard M. Gardner, M.D., Medical Director, New England Neurological Associates, P.C., RIVERWALK, 354 Merrimack Street, Lawrence, MA 01843, or email to [email protected]. Visit us on the web at www.neneuro.com. General Neurology Ochsner Health System is seeking a Board Certified/Board Eligible General Neurologist to practice at Ochsner Medical Center Kenner. While this is primarily an outpatient position, there is also responsibility on the hospital consult service. This physician will become a part of Ochsner Health System’s growing 21-physician Neurology Department. The neurology team includes neurologists with subspecialty expertise in stroke, neurointensive care, movement disorders, epilepsy, pain management, neuroimmunology, neuromuscular disorders, and neuroimaging. Bi-lingual candidates are preferred but not required. Candidates may apply directly from training or from practice. Ochsner Medical Center Kenner is a 125-bed acute care community hospital located in suburban New Orleans. More than 500 employees and 350 physicians are on staff to provide outstanding care to the patients. Ochsner Health System is a physician-led, non-profit, academic, multispecialty healthcare delivery system employing over 800 physicians throughout Southeast Louisiana. We offer a generous and comprehensive benefits package. We also enjoy the advantage of practicing in a favorable malpractice environment in Louisiana. Please visit our website at www.ochsner.org. New Orleans is a cosmopolitan, historic city with unique architecture, multiple medical schools and academic centers, professional sports teams, world-class dining and cultural interests, and world-renowned live entertainment and music. Please e-mail CV to: [email protected], Ref #AGNK03. (800) 488-2240. EOE. Sorry, no J1 visa opportunities available. Neurointensivist/Neurovascular Ochsner Health System North Shore is seeking the following Board Certified/Board Eligible Neurologists: General Neurologist to join a planned group of four neurologists, including 3 general neurologists and 1 Interventional Neurologist/Stroke Specialist. Sub-specialty interest is encouraged. Vascular Neurologist/Interventional Neurologist to lead the development of a Primary Stroke Center at Ochsner Medical Center-North Shore. An interventional suite is currently available at the hospital. Acute stroke consultations are available in the emergency room through stroke telemedicine consults, currently in place in 11 sites in south Louisiana. This physician will join a group of 4 members in the Stroke and Neuro-Critical Care Division of the Department of Neurology. These physicians will become a part of Ochsner Health System’s growing 21-physician Neurology Department. This neurology team includes neurologists with subspecialty expertise in stroke, neurointensive care, movement disorders, epilepsy, pain management, neuroimmunology, neuromuscular disorders, and neuroimaging. Teaching involvement with medical students and residents is encouraged but not required. The telemedicine stroke program at Ochsner Medical Center-North Shore is integrated with our large tertiary care center on Jefferson Highway in New Orleans. In addition, the North Shore will have the availability of neuro-subspecialists in movement disorders, epilepsy, cognitive disorders, and MS on a regular and periodic basis. The North Shore Region offers an excellent referral base with over 100 physicians and mid-level providers with ten locations in five communities. Ochsner Health System is a physician-led, non-profit, academic, multi-specialty, healthcare delivery system employing over 800 physicians throughout Southeast Louisiana. We conduct over 300 ongoing clinical research trials annually. We offer a generous and comprehensive benefits package. We also enjoy the advantage of practicing in a favorable malpractice environment in Louisiana. Please visit our website at www.ochsner.org. Please e-mail CV to [email protected]. Call (800) 488-2240. Ref #. EOE. Sorry, no J-1 visa opportunities available. General Neurology & Vascular/Interventional Neurology Ochsner Health System in New Orleans is seeking a Board Certified/ Board Eligible Neurologist with fellowship training in Neurointensive Care or Neurovascular to join its large tertiary referral program. Interest in acute stroke care, participation in a stroke fellowship training program, teaching in a neurology residency program, care of neurosurgical patients, interacting with a robust stroke program and an active tertiary referral program for neurological disease are all important. Interest in neuroscience is preferred but not required. Both newly trained and experienced physicians are encouraged to apply. Ochsner Health System’s growing 21-physician Neurology team includes neurologists with subspecialty expertise in stroke, neurointensive care, movement disorders, epilepsy, pain management, neuroimmunology, neuromuscular disorders, and neuroimaging. Ochsner’s Department of Neurology is a recipient of the HealthGrades Stroke Care Excellence Award with a five-star ranking. In addition, we ranked #1 in Louisiana for the treatment of stroke. We also have an accredited EMG and Sleep lab. Ochsner Health System is a physician-led, academic, multi-specialty, non-profit healthcare delivery system. We employ over 800 physicians, and our system includes 8 hospitals and 38 health centers. We also enjoy the advantage of practicing in a favorable malpractice environment in Louisiana. Please visit our website, www.ochsner.org for more information. Ochsner Health System and The University of Queensland Medical School in Brisbane, Australia began a unique, joint partnership in 2009 by opening the University of Queensland School of Medicine Clinical School at Ochsner, providing U.S. medical students with an unprecedented educational experience. New Orleans is a cosmopolitan, historic city with a pleasant climate, unique architecture, multiple medical schools and academic centers, professional sports teams, world-class dining and cultural interests, and world-renowned live entertainment and music. Please email CV to [email protected], or call: (800) 488-2240 for additional information. Ref #ARNN05. EOE. Sorry, no J1 visa opportunities available. Employed Neurology and Epilepsy Opportunities Neurological Associates, a well-established, employed practice of 16 Neurologists and Neurosurgeons in Columbus, Ohio, is seeking a Vascular Neurologist. Practice at Riverside Methodist Hospital, a 1,000+ bed, tertiary care teaching hospital. Riverside ranks 1st in inpatient stroke volume in Ohio and was named a “Top 50 Neurology and Neurosurgery Hospital” by U.S. News & World Report. Participate in OhioHealth’s Stroke Network, which involves a partnership between local and remote hospitals via telemedicine, to provide the most advanced stroke care. Plans set to build a new Neuro tower, which will expand neurological services and give Riverside the only dedicated neuro tower in the region. Neurological Associates practices cutting-edge stroke treatments and offers teaching opportunities to its physicians. Enjoy working with a support system of 9 Neurologists and 5 full-time NPs. Practice in the 15th largest city in the nation and Ohio’s capital. Contact Ilene Morrow, Physician Recruiter, at (614) 544-4222 or [email protected] Vascular Neurology Physician A well-established practice of 16 Neurologists and Neurosurgeons in Columbus, Ohio is seeking a Neurologist and an Epileptologist. The group is comprised of some of the most highly regarded physicians in the Midwest. Practice at Riverside Methodist Hospital, a “Top 50 Neurology and Neurosurgery Hospital” by U.S. News & World Report. Employed practice with competitive compensation and retirement packages. Riverside has the 2nd highest Neuroscience volume in the state and ranks 1st in inpatient stroke volume. Opportunity to work with OhioHealth’s Stroke Network involving local and remote hospitals via telemedicine to provide advanced stroke care. The Epileptologist will have the opportunity to assist in the development of our growing Epilepsy program. Plans in place to build a new neuro tower, expanding our neurological services and will be the only dedicated neuro tower in the region. For more information, please contact Ilene Morrow at (614) 544-4222, or email your CV to [email protected]. AANnews • September 2011 35 UPCOMING DATES AND DEADLINES Neurointensivist/Hospitalist Sacred Heart Medical Center a regional referral center has an outstanding clinical opportunity in western Oregon for an energetic BE/BC hospital based Neurologist with an interest/experience in Vascular and/or Neurocritical Care. The ideal candidate will act as a hospital consultant to assist in the management of patients with stroke and other acute neurologic conditions. This position is fulltime, hospital employed with competitive compensation and comprehensive benefits. We seek an individual who would have an interest in our Joint Commission certified primary stroke program, clinical research and tele-medicine services. This individual will excel and enjoy consulting with primary care physicians. Critical care experience required. Eugene, Oregon is one of the most desirable cities in the Pacific Northwest in which to live, work and play. The area is extraordinarily rich in recreational areas as well as cultural activities and the arts. With only an hour’s drive you can also find adventures at the beach or the mountains. Send CV to Nancy Dunlap at: [email protected] or fax to (541) 349-8036, or call Nancy at (541) 222-2502. Neurointensivist/Hospitalist Sacred Heart Medical Center a regional referral center has an outstanding clinical opportunity in western Oregon for an energetic BE/BC hospital based Neurologist with an interest/experience in Vascular and/or Neurocritical Care. The ideal candidate will act as a hospital consultant to assist in the management of patients with stroke and other acute neurologic conditions. This position is fulltime, hospital employed with competitive compensation and comprehensive benefits. We seek an individual who would have an interest in our Joint Commission certified primary stroke program, clinical research and tele-medicine services. This individual will excel and enjoy consulting with primary care physicians. Critical care experience required. Eugene, Oregon is one of the most desirable cities in the Pacific Northwest in which to live, work and play. The area is extraordinarily rich in recreational areas as well as cultural activities and the arts. With only an hours drive you can also find adventures at the beach or the mountains. Send CV to Nancy Dunlap at: [email protected] or fax to (541) 349-8036, or call Nancy at (541) 222-2502. Medical Director - Stroke Program Opportunities for BC/BE Vascular and General Neurologists to complement an existing two person Neurology practice, part of Saint Francis Medical Group, a 200 provider multi-specialty group affiliated with Saint Francis Hospital and Medical Center in Hartford, CT. Existing Neurologists include a Stroke and General Neurologist, complemented by two Nurse Practitioners. To qualify for the Vascular Neurology position, you will have completed a fellowship in Vascular Neurology and be BC/BE. Responsibilities include inpatient general neurology and stroke consultations, as well as outpatient neurology; call 1:4. Saint Francis Hospital and Medical Center is a 617-bed tertiary care hospital located in Hartford, CT and has a Joint Commission and CT DPH accredited Stroke Center. The hospital is affiliated with the University of Connecticut for both undergraduate and graduate medical education. Contact Christine Bourbeau, Director, Physician Recruitment, at 855.894.5590 or email your Curriculum Vitae to [email protected] website: www.stfranciscare.org Vascular and General Neurology Opportunities - Central Connecticut Are you a BC Vascular Neurologist seeking to advance your career as a leader within a comprehensive stroke program? We can make that happen. Saint Francis Hospital and Medical Center has an exciting opportunity for an exceptional Vascular Neurologist to serve as the Medical Director of our Stroke Program within our comprehensive Stroke Center in Hartford, CT. This is an opportunity to lead an established multi-disciplinary team, develop clinical expertise, and provide a vision for our Stoke Program’s continued advancement. This position benefits from an academic affiliation with the University of Connecticut and multi-specialty support from one of the largest hospitals in Connecticut. The ideal candidate should have demonstrated an ability to lead in a clinical team environment, have an outstanding history of clinical care and an interest in teaching and providing visionary leadership. If you are ready to advance in your career, we can make that happen. Contact Christine Bourbeau today at (855) 894-5590 or email your CV and letter of interest to [email protected]. www.saintfranciscare.com Neurologist GWV The Geisinger Neurosciences Institute at Geisinger Wyoming Valley Medical Center in Wilkes-Barre, PA, is seeking a stroke neurologist, a general neurologist, a Neurohospitalist, and an aging brain specialist for its rapidly expanding department. Located within 2.5 hours of New York City and Philadelphia, this region offers an excellent quality of life with access to numerous activities and affordable housing. Geisinger Health System is a physician-led, patient-focused, integrated delivery system that uses a mature electronic health record connecting more than 800 physicians over a 40-county area serving nearly 3 million people. Visit www.join-geisinger.org or contact Lori Surak at [email protected] or (800) 845-7112. BC/BE Neurologist & Pediatric Neurologist This Place is Amazing. So is the difference you can make. Greenville Hospital System University Medical Center (GHS), the largest healthcare provider in South Carolina, is seeking a BC/BE Neurologist to join our dynamic team. BC/BE Neurologist: The Neurology Department has established a protocol driven multi-disciplinary approach to treating a variety of neurological diseases, injuries and pain, including but not limited to epilepsy, movement disorders, neurophysiology and strokes. This Department combines efforts with Neurosurgery and Physiatry. We're also seeking a Pediatric Neurologist to work at our Children's Hospital that offers a broad range of comprehensive subspecialty services. Our system includes clinically excellent facilities with 1,268 beds on 5 campuses. Additionally, we offer 7 residency programs, 5 fellowships, a level-one trauma center and a research facility. And in 2012, our Medical School will be opening in conjunction with USC at our main downtown campus. Greenville, South Carolina is located on the I-85 corridor between Atlanta and Charlotte, and is one of the fastest growing areas in the country. We are ideally situated near beautiful mountains, beaches and lakes. We offer a great compensation package that includes excellent benefits. Qualified candidates should submit a CV to: Ericka Splawn, Physician Recruiter, at [email protected]. Or call (877) 360-5579. www.ghs.org. No Visa Sponsorship available. Greenville Hospital System University Medical Center is an equal opportunity employer which proudly values diversity. Candidates of all backgrounds are encouraged to apply. Country Doctor? Big-City Superstar? Be Both. Tanner Health System, the healthcare provider of choice in west Georgia and east Alabama, has an immediate opening for two neurologists. Join Tanner Neurology, an established practice that is part of Tanner Medical Group, one of metro Atlanta’s largest multi-specialty physician groups. Practice as an employed physician from a single, outpatient office location with 1:4 hospital call rotation, serving a dynamic community on the outskirts of Atlanta with unparalleled charm and character, excellent schools and recreational opportunities, a thriving arts scene, a state university and more. Call (770) 838-8729 or email [email protected] for more information on this excellent opportunity. Learn more at www.tannerphysicianrecruitment.org. Seeking Neurologist For Spine Center Diagnosis/Initial Consult The New Jersey Center For Spinal Disorders seeks an energetic and skilled neurologist to assist in the diagnosis, evaluation, and management of patients with spinal disorders. We have a bright, newly renovated office in the heart of beautiful Englewood, NJ located only 5 miles from New York City. Just down the street from Englewood Hospital, and Health East Medical Center. To learn more about this opportunity, please contact us directly, or submit your CV. www.mybackcure.com Employed Neurology Arizona Scottsdale Healthcare (SHC) Shea is seeking a Fellowship Trained Epileptologist with experience to establish and run a new Epilepsy Monitoring Unit which will encompass outpatient epilepsy clinic services and in-patient services involved with the operation of the EMU. As an Employee of Scottsdale Healthcare, you will have exceptional team support and necessary technical, administrative and marketing resources for the development and on-going success of a World Class Epilepsy Program. The Epilepsy Program will be a destination center for the region as accessibility to EMU services is vastly underserved in the state of Arizona. In addition, you will have the opportunity to maintain your general Neurology skills providing Neuro-Hospitalist services for approximately eight weeks per year. All in-patient and out-patient clinical services will be provided at the SHC Shea Campus, located in desirable North Scottsdale with excellent schools, restaurants and year round recreation as a city built in the base of beautiful McDowell Mountains. In addition, Scottsdale Health care offers exceptional benefits to include professional liability, relocation, housing allowance and many other benefits you would expect from a system devoted to "World Class Patient Care." Please call Laura Hays (480) 391-9777 or (888) 391-9777 or email CV [email protected] or fax (480) 772-4566 Epileptologist/Neuro-Hospitalist The Practice: Practice in a community where you can make a difference. Medical staff will welcome your expertise in Neurological services. Patients will benefit from not having to travel. Practicing and 2012 Neurology Residents encouraged to apply. TeleStroke consultation and access to Medicine Ground Rounds provided via contract with Mayo Clinic Scottsdale. Hospital Employed position offers: competitive salary guarantee, comprehensive Benefits, malpractice insurance, relocation expenses. Hospital is financially sound. Medical staff is collegial and opted to practice in the white mountains to avoid the hassles and politics of metro area medicine. Life is good when you remove stress points (traffic, politics, competition etc.). The Region: the white mountains is comprised of several close knit communities of full-time residents surrounded by resort communities that attract visitors that enjoy hiking, fishing, hunting, golf, water sports, snow skiing and nice people. Please call Laura Hays 480-391-9777 or (888) 391-9777 or email CV [email protected] or fax (480) 772-4566. General Neurologist Needed for Busy East Texas Practice Your opinion will be valued as a member of our dynamic neuroscience team. Trinity Mother Frances Hospitals and Clinics in Tyler, Texas, home to one of the most comprehensive neurosurgery programs in east Texas, is adding a fifth neurologist to our growing department. Trinity Mother Frances Neuroscience Institute is staffed by specialists in neurosurgery, neurology, physical medicine and rehabilitation, pain medicine, sleep medicine and stroke. Combined with the awardwinning clinical resources of Mother Frances Hospital, we offer state-of-the-art patient care facilities and the latest surgical and treatment technologies. Enjoy an outstanding production-based compensation package; relocation assistance, no tail malpractice and no clinic buy in. Tyler is a major medical referral center with more than one million draw and is a growing certified retirement community. If you’re seeking an exceptional lifestyle balance, this is the opportunity for you. Trinity Clinic is comprised of over 270 physicians in 37 specialties serving north central, east, and northeast Texas. Community Description: Tyler is located just 100 miles from Dallas and is recognized as among the most desirable places to work and is also a certified retirement community. A national leader in patient satisfaction, advanced technology and quality initiatives, Trinity Mother Frances is a faith-based, not-for-profit organization dedicated to creating healthy lives for people and communities. For additional information, please contact Tonya Hamlin, Director, Physician Recruitment, [email protected]. (903) 531-4906. Code: MFH032211 Seeking Neurologists General and interest in Epileptology UPMC Hamot in Erie, Pennsylvania is seeking a general neurologist with training and interest in hospital based care and/or epileptology to join a busy physician owned neurology practice. This is an excellent opportunity to join a rapidly growing Neuroscience Service Line at a Level 2 Trauma Acute care Medical Center that includes a neurology residency program. Call will be 1:8 as well as excellent compensation and benefits. Lifestyle that includes living along Lake Erie. Contact Sue McCreary, Physician Recruiter at (814) 877-3403 or [email protected]. Visit us at www.hamot.org. Neurologist Wenatchee Valley Medical Center in North Central Washington State is seeking a 5th Neurologist. Practice is 90% outpatient; inpatient is consultative with robust hospitalist program. General neuro with sub-specialty interest welcome, clinical neuro-physiology fellowship preferred. We’re the only Neurologists for 12,000 sq. miles; patient draw of 235k. Market-responsive salary, partnership, comprehensive benefits, retirement. Paperless and efficient. Collegial medicine at its best. Physician-owned and patient-centered since 1940. Now that’s Serious Medicine. Over 300 days of sunshine with mild 4-season climate amidst mountains, rivers, and lakes. Skiing, biking, paddling, golf, you name it. No traffic jams. “Small” town of 65k with plenty of amenities. Yeah, Serious Fun. Email CV to Peter Rutherford, MD at [email protected]. Learn more at www.wvmedical.com. SEPTEMBER 2011 SUN MON TUE WED OCTOBER 2011 THU FRI SAT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 18 19 20 21 22 23 25 26 27 28 29 30 SEPTEMBER 18 Application Deadline: Palatucci Advocacy Leadership Forum www.aan.com/view/2012PALF Melissa Larson [email protected] SEPTEMBER 20 Win, Lose, or Draw? Negotiating with Hospitals and Insurers (Register by September 16) www.aan.com/go/practice/coding/ conferences Christi Kokaisel [email protected] SUN MON TUE WED THU NOVEMBER 2011 FRI TUE WED THU FRI 1 2 3 4 5 4 5 6 7 8 6 7 8 9 10 11 12 17 9 10 11 12 13 14 15 13 14 15 16 17 18 19 24 16 17 18 19 20 21 22 20 21 22 23 24 25 26 23 24 25 26 27 28 29 27 28 29 30 30 31 OCTOBER 10–14 Neurology Career Week Create your online career profile www.aan.com/career OCTOBER 15 Application Deadline: 2012-2013 Viste Neurology Public Policy Fellowship www.aan.com/viste Mike Amery [email protected] OCTOBER 18 OCTOBER 21–23 2011 Fall Conference, Las Vegas, NV www.aan.com/view/fall2011 OCTOBER 24 Deadline: Abstract Submissions for 2012 Annual Meeting Erin Jackson [email protected] (651) 695-2704 NOVEMBER 1 Deadline: AAN Scientific Awards www.aan.com/2012awards Erin Jackson [email protected] (651) 695-2704 Deadline: Patient Safety Award Amy Wallace [email protected] (651) 695-2817 Deadline: Resident Scholarship to the Annual Meeting Cheryl Alementi [email protected] (651) 695-2737 Deadline: Program Directors Recognition Award Lucy Persaud [email protected] (651) 695-2741 Deadline: International Scholarship Award Franziska Schwarz [email protected] (651) 695-2807 NOVEMBER 8 ICD-10: What You Need to Know for 2012 (Register by November 4) www.aan.com/go/practice/coding/ conferences Christi Kokaisel [email protected] (651) 695-2810 NOVEMBER 30 AANnews Classified Advertising Deadline: Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award Julie Grengs [email protected] (651) 695-2755 The AAN offers a complete package of print, online, and in-person recruitment advertising opportunities. Visit www.aan.com/careers for all AAN options, rates, and deadlines. Ad copy for the November 2011 print edition of AANnews must be submitted by October 1, 2011. The same deadline applies to changes/cancellations. The American Academy of Neurology reserves the right to decline, withdraw, or edit advertisements at its discretion. Every care is taken to avoid mistakes, but the responsibility for clerical or printer errors does not exceed the cost of the ad. AANnews • September 2011 36 SAT 3 SEPTEMBER 30 Baltimore, Maryland Area Baltimore, Maryland area: Seeking BC/BE neurologist to join a busy highly-respected suburban general neurology private practice, affiliated with several local community and teaching hospitals. EEG/EMG fellowship training and/or experience preferred but not mandatory. Flexible compensation and benefits package with early partnership available for qualified candidate. Locale enjoys reasonable cost of living enhanced by many cultural, recreational, and educational opportunities too numerous to list. Visit website at www.taylormedicalgroup.com. Mail detailed contact information and resume to: Richard L. Taylor, MD, FAAN, Taylor Medical Group, 22 West Road, Suite 101, Towson, MD 21204-2388. MON 2 Deadline: AAN Fall Conference Early Registration Discount www.aan.com/view/fall2011 Registration Deadline: EBM Toolkit Training www.aan.com/education/ebm Rebecca Penfold Murray [email protected] (651) 695-2735 SUN 1 Coding Accurately for Epilepsy (Register by October 14) www.aan.com/go/practice/coding/ conferences Christi Kokaisel [email protected] (651) 695-2810 SEPTEMBER 27 SAT AAN FALL CONFERENCE AAN ANNUAL MEETINGS 2011 / Las Vegas October 21–23 2012 / New Orleans April 21–28 2013 / San Diego March 16–23 2014 / Philadelphia April 26–May 3
Similar documents
2015 Annual Meeting Medical Students, Residents, and Fellows Guide
If you’re looking for a one-of-a-kind opportunity to update or extend your knowledge of neurology and neuroscience, develop new friendships, and connect with colleagues who may well prove helpful i...
More information